data_1z86_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z86 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 111' ' ' ILE . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.714 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 106' ' ' ILE . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 94' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.804 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.447 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 ' O ' ' A' ' 93' ' ' GLY . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.806 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.441 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.403 HG23 ' CB ' ' A' ' 117' ' ' ALA . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 111' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.806 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.441 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 117' ' ' ALA . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.47 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 106' ' ' ILE . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 124' ' ' PHE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 94' ' ' ILE . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.459 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.801 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.422 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 124' ' ' PHE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 111' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.81 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.461 HG21 HG22 ' A' ' 111' ' ' ILE . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.408 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 125' ' ' VAL . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 124' ' ' PHE . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 108' ' ' ILE . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.801 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.666 0.27 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 93' ' ' GLY . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.816 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 125' ' ' VAL . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 111' ' ' ILE . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.4 HD11 ' CG2' ' A' ' 94' ' ' ILE . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.453 ' N ' HD13 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.816 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.4 ' CB ' ' CB ' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.693 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.794 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.448 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 93' ' ' GLY . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.707 HG13 ' HE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 106' ' ' ILE . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 124' ' ' PHE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 140' ' ' ALA . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.81 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 111' ' ' ILE . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.808 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 94' ' ' ILE . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.808 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HG2' ' CB ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 158' ' ' LEU . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.589 -0.204 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.718 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.784 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 124' ' ' PHE . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 94' ' ' ILE . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.414 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.784 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 43.4 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.705 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.819 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.459 ' CG2' HG13 ' A' ' 111' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.459 HG13 ' CG2' ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD1' HG23 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.819 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.7 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.778 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.778 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.943 0.401 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.7 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.822 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.402 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.822 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.842 0.353 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.813 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.409 ' CA ' HD12 ' A' ' 123' ' ' LEU . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 ' CA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.813 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.819 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.451 HG22 HD11 ' A' ' 106' ' ' ILE . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 124' ' ' PHE . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.819 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.418 ' CB ' ' CB ' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.417 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.866 0.365 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.403 HG23 ' CB ' ' A' ' 117' ' ' ALA . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.811 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.42 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 124' ' ' PHE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.442 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.7 p30 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.811 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.42 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.701 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 125' ' ' VAL . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' HD11 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.814 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.811 0.338 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.419 HG21 ' CG2' ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.708 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.806 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.454 HG22 HD13 ' A' ' 106' ' ' ILE . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.419 ' CG2' HG21 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' A' ' 106' ' ' ILE . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 145' ' ' ALA . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.806 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.408 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.623 -0.191 . . . . 0.0 112.623 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 117' ' ' ALA . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.808 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.426 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.427 HG22 ' CD1' ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 95' ' ' SER . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 124' ' ' PHE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.408 ' CB ' HG22 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.464 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.808 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 158' ' ' LEU . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.699 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 124' ' ' PHE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . 0.44 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' HIS . . . . . 0.804 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 169.99 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -126.03 135.04 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -92.04 129.65 37.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -110.16 131.42 55.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.75 -76.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.27 98.56 3.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -175.72 -64.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.12 -49.13 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.41 -94.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 9.2 mp -103.97 178.78 4.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.837 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -167.77 59.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.372 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 111' ' ' ILE . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.714 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 106' ' ' ILE . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 94' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.415 ' O ' ' CD1' ' A' ' 123' ' ' LEU . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.804 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.447 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.447 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.415 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.43 98.31 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.8 mmm -131.44 28.35 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 151.45 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.924 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.93 160.22 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 t -102.66 134.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -122.85 144.98 48.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -65.55 102.86 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.51 -32.88 6.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.58 -178.83 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.796 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.08 -57.56 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 132.67 50.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.03 131.96 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.02 -178.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 94' ' ' ILE . . . 167.21 66.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.54 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.401 HG21 ' O ' ' A' ' 93' ' ' GLY . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.806 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.441 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.403 HG23 ' CB ' ' A' ' 117' ' ' ALA . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 111' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.403 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.806 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.441 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -69.88 103.88 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -0.99 9.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.35 -78.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.889 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.788 0.328 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -145.98 149.18 33.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.759 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.52 129.98 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.01 112.15 24.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.15 85.12 6.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.74 -49.25 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -32.93 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.99 122.55 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.046 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.07 99.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.18 -179.92 18.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.75 -75.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.881 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 111.32 59.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.646 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.405 HG22 ' CB ' ' A' ' 117' ' ' ALA . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.47 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 106' ' ' ILE . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG13 ' HA ' ' A' ' 124' ' ' PHE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' CB ' HG22 ' A' ' 94' ' ' ILE . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.459 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.801 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.422 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -69.74 108.15 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.78 8.92 12.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.366 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 pttm 45.81 -168.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.436 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.865 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.849 0.357 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -143.17 151.46 40.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -127.57 138.67 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.99 138.33 53.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 157.52 34.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.99 -30.96 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.99 73.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 59.86 94.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.01 88.85 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.84 157.74 17.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.84 -172.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.84 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.02 64.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.353 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.423 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 124' ' ' PHE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.4 ' HB2' HG22 ' A' ' 111' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.438 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.81 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.423 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.85 100.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 7.7 mtm -91.29 -16.68 27.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.342 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 61.34 -81.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.895 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -148.62 153.11 37.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.02 142.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -90.96 159.38 16.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -95.54 145.9 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -75.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -176.77 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 -31.46 7.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.57 -92.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.88 -129.64 8.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 pp -93.89 126.83 39.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.66 70.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.461 HG21 HG22 ' A' ' 111' ' ' ILE . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.408 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.427 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 125' ' ' VAL . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 124' ' ' PHE . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.481 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 108' ' ' ILE . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.801 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.427 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.455 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.87 85.05 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 75.3 mtm -111.6 18.2 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 40.52 75.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.828 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.796 0.332 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -149.48 155.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -108.15 148.17 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.9 117.44 29.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 131.56 35.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.31 175.51 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.81 -32.14 70.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.998 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.01 91.43 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.78 152.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.603 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.72 -139.28 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.54 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -59.98 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.849 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' ILE . . . 108.82 50.4 0.74 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 93' ' ' GLY . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.816 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.408 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.453 HD13 ' N ' ' A' ' 125' ' ' VAL . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 111' ' ' ILE . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.4 HD11 ' CG2' ' A' ' 94' ' ' ILE . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.453 ' N ' HD13 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.816 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.4 ' CB ' ' CB ' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.408 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.445 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.06 98.3 7.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -5.99 58.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.334 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.33 163.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.95 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.834 0.35 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 154.17 38.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -108.81 142.94 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.74 133.54 35.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.051 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -164.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.42 32.73 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.76 122.91 36.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.25 121.6 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.0 -23.0 35.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.95 -73.88 2.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -119.4 179.45 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -168.22 80.4 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.491 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.693 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.407 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.794 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.448 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -69.95 100.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.6 23.42 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.069 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 59.22 161.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.971 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.781 0.324 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.91 137.35 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.21 141.41 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 141.49 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -66.97 139.07 57.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.26 179.1 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.145 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -48.5 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.47 81.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.063 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 108.42 129.6 6.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.37 -53.21 1.48 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.9 mt -110.22 158.08 18.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.405 ' O ' ' CG2' ' A' ' 94' ' ' ILE . . . -149.74 72.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.387 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.405 ' CG2' ' O ' ' A' ' 93' ' ' GLY . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.498 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.707 HG13 ' HE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 106' ' ' ILE . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.465 HG13 ' HA ' ' A' ' 124' ' ' PHE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.412 ' O ' ' O ' ' A' ' 140' ' ' ALA . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.81 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.418 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.447 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 110.55 5.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 13.3 mtt -135.03 21.74 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 117.4 11.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.981 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.35 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.53 154.94 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.88 147.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -110.81 126.88 55.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.39 171.5 13.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.74 -47.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.1 178.51 5.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.02 133.38 40.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.73 -46.84 0.67 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.02 -144.75 15.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.469 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.66 176.44 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.917 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.08 79.31 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 111' ' ' ILE . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.457 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.808 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.421 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 94' ' ' ILE . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' HD12 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.49 ' CB ' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.808 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.49 ' HG2' ' CB ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.98 92.39 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.5 mtp -95.07 -4.85 45.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 166.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.847 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.953 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.697 0.284 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -123.92 156.84 35.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.441 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 158' ' ' LEU . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.59 136.42 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.72 148.09 28.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -135.19 31.59 3.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 169.65 3.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.04 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -174.78 175.45 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.77 -164.06 12.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.64 160.87 30.98 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.428 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.72 -176.78 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -149.54 77.47 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.589 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.467 HG22 HD12 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.451 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.718 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.784 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.451 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 124' ' ' PHE . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' ' CG2' ' A' ' 94' ' ' ILE . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.414 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.784 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.421 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 43.4 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 82' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.441 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -69.9 93.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.12 10.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.529 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt 55.03 27.22 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.961 -179.876 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.784 0.326 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.89 146.3 26.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.788 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t -109.02 125.6 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -87.68 134.81 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -89.71 118.58 29.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.05 178.04 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -53.52 45.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 93.35 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.97 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.06 -174.57 34.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.408 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.33 119.91 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.33 75.46 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.705 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.819 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.459 ' CG2' HG13 ' A' ' 111' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.459 HG13 ' CG2' ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.406 ' CD1' HG23 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.406 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.819 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.432 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.9 101.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.1 ptm -148.38 28.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.992 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 121.19 11.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.839 0.352 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -170.01 157.83 6.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t -101.34 125.88 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 112.62 25.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -109.65 72.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.58 -35.34 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -84.19 -174.42 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 100.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.12 -165.75 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.04 40.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.78 -170.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.46 76.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.405 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.431 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.7 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.778 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.421 HD13 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.432 HG22 ' CD1' ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.401 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.778 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.475 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.475 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -106.66 106.35 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.8 mtt -109.0 -3.84 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -71.39 137.6 48.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.743 0.306 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -150.14 153.84 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.95 140.48 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 134.01 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -86.43 171.64 10.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.82 30.12 19.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.34 -43.43 2.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -163.05 30.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.36 -167.48 23.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.44 53.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.489 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.6 tp 60.36 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 96.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.59 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 111' ' ' ILE . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.7 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.822 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.402 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 94' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.822 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.79 99.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mmt -110.86 -3.93 15.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.468 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -43.62 6.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 156.31 6.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.91 135.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 143.4 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -71.59 81.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.24 95.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.057 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.15 -79.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.8 115.35 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.9 107.95 0.25 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.437 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.48 -76.03 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.504 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.95 160.77 39.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.786 0.327 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -160.83 72.4 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.813 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.413 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.409 ' CA ' HD12 ' A' ' 123' ' ' LEU . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 ' CA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.813 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.413 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -70.01 101.47 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.21 -8.17 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.394 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 tttt 63.2 133.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.879 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -159.15 145.89 16.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.769 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 t -100.47 128.49 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -86.45 130.11 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.72 163.34 17.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.13 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -167.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 62.2 178.87 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.78 -60.07 5.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.63 -104.11 0.66 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.88 -64.55 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 125.06 58.61 0.17 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.45 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.819 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.451 HG22 HD11 ' A' ' 106' ' ' ILE . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.45 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 124' ' ' PHE . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.401 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.819 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.418 ' CB ' ' CB ' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.417 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 95.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.5 mtt -124.84 23.57 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.183 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.39 111.21 12.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.881 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.29 149.79 27.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.8 t -123.8 125.13 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.08 138.6 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -71.69 -179.57 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 -69.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.8 -66.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.2 -52.69 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.58 153.85 46.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.73 82.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp 59.9 109.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -141.46 82.27 0.23 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.492 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.403 HG23 ' CB ' ' A' ' 117' ' ' ALA . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.433 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.811 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.42 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.442 HG13 ' HA ' ' A' ' 124' ' ' PHE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.442 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.7 p30 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.406 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.811 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.42 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -69.71 109.48 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.36 2.0 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.251 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 131.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.935 0.398 . . . . 0.0 110.959 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.925 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.83 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.53 143.7 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -116.89 143.17 46.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.14 166.91 23.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.74 -174.63 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.94 -30.81 66.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.15 130.65 56.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.53 -155.38 33.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.3 157.22 33.2 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 tp 62.13 150.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 176.22 69.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.545 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.404 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.701 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.814 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HD11 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 125' ' ' VAL . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' HD11 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 158' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.814 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.414 ' CB ' HD11 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.413 ' HG ' ' HB ' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.86 116.95 10.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mtp -117.47 -4.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.319 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 61.57 156.18 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.865 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.856 0.36 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -158.23 164.85 36.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -130.87 130.57 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.99 162.3 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 88.91 3.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.25 171.57 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -65.9 -31.73 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.76 33.12 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.01 179.0 51.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -116.22 -169.38 15.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.551 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 mt 59.38 -179.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 132.78 66.94 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.513 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.419 HG21 ' CG2' ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.708 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.806 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.454 HG22 HD13 ' A' ' 106' ' ' ILE . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.419 ' CG2' HG21 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.4 ' CD1' HG21 ' A' ' 106' ' ' ILE . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 145' ' ' ALA . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.806 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 147' ' ' GLN . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.421 ' CB ' HD13 ' A' ' 106' ' ' ILE . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.408 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -69.95 110.03 4.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.6 mmt -145.14 28.13 1.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -140.58 158.93 43.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.887 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.807 0.337 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.22 142.19 7.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.795 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t -103.8 141.45 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.65 114.21 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -91.42 72.29 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.41 -70.68 0.3 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -143.17 -56.18 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.822 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.81 115.25 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.35 112.47 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.52 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -140.11 86.63 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.575 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 45.64 -168.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.755 0.312 . . . . 0.0 111.425 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 143.05 77.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.623 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 HG22 ' CB ' ' A' ' 117' ' ' ALA . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.711 HG13 ' HE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.808 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.401 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.426 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.427 HG22 ' CD1' ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 95' ' ' SER . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.404 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.464 HG13 ' HA ' ' A' ' 124' ' ' PHE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.408 ' CB ' HG22 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.464 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.413 ' O ' ' O ' ' A' ' 141' ' ' THR . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.808 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 158' ' ' LEU . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.409 ' CD2' ' CD2' ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.93 100.86 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.5 mtt -112.55 -5.89 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.37 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 170.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.727 0.298 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 163.75 27.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.51 140.1 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 120.62 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.27 79.31 4.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 37.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.056 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.17 23.95 5.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.076 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 53.82 29.42 9.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.571 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 127.84 -120.7 3.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.434 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.11 147.29 29.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.993 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.99 84.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.441 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.43 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.699 HG13 ' HE2' ' A' ' 142' ' ' HIS . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 124' ' ' PHE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . 0.44 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.804 ' NE2' ' HA ' ' A' ' 97' ' ' LYS . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -70.64 108.28 4.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.84 27.98 6.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.014 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? 68.33 -68.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 123' ' ' LEU . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.04 HG11 ' HB1' ' A' ' 116' ' ' ALA . 25.9 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 117' ' ' ALA . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.719 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.499 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 127' ' ' ASP . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 108' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' N ' HG22 ' A' ' 111' ' ' ILE . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.409 HD13 ' HA3' ' A' ' 93' ' ' GLY . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 1.04 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.713 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.612 ' HA ' HD13 ' A' ' 111' ' ' ILE . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HA ' HG12 ' A' ' 160' ' ' VAL . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 149' ' ' LEU . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 145' ' ' ALA . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.823 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.808 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.503 HD12 ' CD1' ' A' ' 96' ' ' ILE . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 123' ' ' LEU . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG11 ' HB1' ' A' ' 116' ' ' ALA . 30.7 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 117' ' ' ALA . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.855 HG22 HD12 ' A' ' 129' ' ' ILE . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.724 HG21 HD11 ' A' ' 111' ' ' ILE . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 125' ' ' VAL . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.84 ' HA ' HG22 ' A' ' 94' ' ' ILE . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 115' ' ' LEU . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 109' ' ' SER . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.855 HD12 HG22 ' A' ' 106' ' ' ILE . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.917 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.861 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.917 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.635 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 142' ' ' HIS . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 158' ' ' LEU . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.855 ' HD2' HG12 ' A' ' 146' ' ' VAL . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.451 ' CB ' HG22 ' A' ' 156' ' ' VAL . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.451 HG22 ' CB ' ' A' ' 152' ' ' THR . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 122' ' ' ALA . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 158' ' ' LEU . 21.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.69 HG22 ' HA ' ' A' ' 111' ' ' ILE . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.641 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 111' ' ' ILE . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.936 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 126' ' ' GLY . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 108' ' ' ILE . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.684 ' HA ' HG12 ' A' ' 160' ' ' VAL . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.846 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.895 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.641 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 96' ' ' ILE . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.505 ' O ' HD12 ' A' ' 158' ' ' LEU . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 156' ' ' VAL . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.715 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 1.056 HG22 HG23 ' A' ' 111' ' ' ILE . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.718 HD13 HD12 ' A' ' 149' ' ' LEU . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.8 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 127' ' ' ASP . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 125' ' ' VAL . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.056 HG23 HG22 ' A' ' 94' ' ' ILE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.686 ' HB3' HD12 ' A' ' 115' ' ' LEU . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 112' ' ' PHE . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 109' ' ' SER . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.728 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 160' ' ' VAL . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.698 ' OD1' HG13 ' A' ' 156' ' ' VAL . 1.6 m120 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.046 HD23 ' HB3' ' A' ' 140' ' ' ALA . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.046 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.587 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 148' ' ' ALA . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.698 HG13 ' OD1' ' A' ' 133' ' ' ASN . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 129' ' ' ILE . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.465 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.561 ' OG1' HG22 ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 117' ' ' ALA . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.787 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.705 HG21 HD11 ' A' ' 111' ' ' ILE . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 123' ' ' LEU . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.818 ' O ' HD13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.595 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 160' ' ' VAL . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 130' ' ' LEU . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 137' ' ' LEU . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 132' ' ' VAL . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.81 HD21 ' HA ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.749 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.81 ' HA ' HD21 ' A' ' 137' ' ' LEU . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 HD13 ' A' ' 96' ' ' ILE . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 148' ' ' ALA . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 158' ' ' LEU . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.561 HG22 ' OG1' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.666 0.27 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 122' ' ' ALA . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.726 ' CG1' HD11 ' A' ' 158' ' ' LEU . 12.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 123' ' ' LEU . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 127' ' ' ASP . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.633 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 112' ' ' PHE . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.413 ' N ' HD11 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' A' ' 160' ' ' VAL . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 161' ' ' LYS . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 137' ' ' LEU . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 132' ' ' VAL . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.929 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.929 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.586 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 142' ' ' HIS . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 96' ' ' ILE . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 156' ' ' VAL . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 152' ' ' THR . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.726 HD11 ' CG1' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 129' ' ' ILE . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.407 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 123' ' ' LEU . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 116' ' ' ALA . 19.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.666 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.958 HG22 HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 127' ' ' ASP . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 115' ' ' LEU . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.666 HD13 ' HA3' ' A' ' 93' ' ' GLY . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.716 ' HA ' HG12 ' A' ' 160' ' ' VAL . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 HD23 ' A' ' 158' ' ' LEU . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.95 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.834 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.95 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 158' ' ' LEU . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 81' ' ' ARG . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.572 ' CD2' HD21 ' A' ' 149' ' ' LEU . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 123' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 120' ' ' THR . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.768 HG23 HD21 ' A' ' 158' ' ' LEU . 21.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 123' ' ' LEU . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.513 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HE ' HG23 ' A' ' 141' ' ' THR . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.941 HG21 HD11 ' A' ' 111' ' ' ILE . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.941 HD11 HG21 ' A' ' 108' ' ' ILE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 112' ' ' PHE . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.77 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 137' ' ' LEU . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.537 HG23 ' HE ' ' A' ' 100' ' ' ARG . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 152' ' ' THR . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 96' ' ' ILE . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.639 ' HD2' HG12 ' A' ' 146' ' ' VAL . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.694 HG21 HG13 ' A' ' 156' ' ' VAL . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.694 HG13 HG21 ' A' ' 152' ' ' THR . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.768 HD21 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 123' ' ' LEU . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.868 HG22 HD13 ' A' ' 108' ' ' ILE . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.788 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.622 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 96' ' ' ILE . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG12 HD12 ' A' ' 123' ' ' LEU . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 84' ' ' VAL . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.658 ' HA ' HD13 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 108' ' ' ILE . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.568 HD13 ' HD3' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.45 HG23 HD23 ' A' ' 158' ' ' LEU . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.479 ' OD1' HG13 ' A' ' 156' ' ' VAL . 2.5 m120 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 140' ' ' ALA . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.01 ' HB1' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 1.01 ' HG2' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 96' ' ' ILE . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HD3' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.479 HG13 ' OD1' ' A' ' 133' ' ' ASN . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 81' ' ' ARG . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.45 HD23 HG23 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HD3' HD13 ' A' ' 130' ' ' LEU . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HB2' HG23 ' A' ' 160' ' ' VAL . 3.0 mtt180 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 158' ' ' LEU . 21.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.589 -0.204 . . . . 0.0 112.589 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.651 HG23 ' HB2' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.46 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.715 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.774 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.782 HD12 ' HB2' ' A' ' 127' ' ' ASP . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.782 HG12 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 111' ' ' ILE . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.514 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.782 HD12 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.622 ' CG1' HG12 ' A' ' 160' ' ' VAL . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 137' ' ' LEU . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 1.06 HD23 ' HB3' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 1.06 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.831 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.785 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 142' ' ' HIS . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 24.0 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.455 HD22 HD21 ' A' ' 158' ' ' LEU . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 152' ' ' THR . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 84' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.403 ' HB3' HG13 ' A' ' 157' ' ' VAL . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.729 HG11 HD23 ' A' ' 123' ' ' LEU . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.612 ' O ' HG21 ' A' ' 120' ' ' THR . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 94' ' ' ILE . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.805 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.559 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 128' ' ' ALA . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 129' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.702 ' CD1' HG21 ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 115' ' ' LEU . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 112' ' ' PHE . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' C ' HD11 ' A' ' 123' ' ' LEU . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' O ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 108' ' ' ILE . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 161' ' ' LYS . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 132' ' ' VAL . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.833 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.943 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' HIS . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 158' ' ' LEU . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 81' ' ' ARG . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 149' ' ' LEU . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 129' ' ' ILE . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 122' ' ' ALA . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 123' ' ' LEU . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.725 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.762 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD23 ' CA ' ' A' ' 128' ' ' ALA . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.677 HD11 HG21 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 112' ' ' PHE . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.4 ' HA ' HG13 ' A' ' 111' ' ' ILE . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.67 ' OD2' HD12 ' A' ' 108' ' ' ILE . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' CA ' HD23 ' A' ' 107' ' ' LEU . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.715 ' HA ' HG12 ' A' ' 160' ' ' VAL . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.598 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.752 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.598 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 142' ' ' HIS . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 158' ' ' LEU . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 148' ' ' ALA . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 152' ' ' THR . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 149' ' ' LEU . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.943 0.401 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 122' ' ' ALA . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.954 HD13 HD12 ' A' ' 149' ' ' LEU . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.575 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.888 HD12 ' HB2' ' A' ' 127' ' ' ASP . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.768 HD11 HG21 ' A' ' 108' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.74 ' HA ' HD13 ' A' ' 111' ' ' ILE . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.58 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.587 ' CG1' HG12 ' A' ' 160' ' ' VAL . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 161' ' ' LYS . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 137' ' ' LEU . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.709 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.81 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.81 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.709 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 142' ' ' HIS . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.954 HD12 HD13 ' A' ' 96' ' ' ILE . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.6 HG21 HG22 ' A' ' 156' ' ' VAL . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 152' ' ' THR . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 149' ' ' LEU . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.587 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.599 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.842 0.353 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 123' ' ' LEU . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.656 HG22 HG23 ' A' ' 111' ' ' ILE . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.687 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.802 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 125' ' ' VAL . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.685 HG23 ' HB1' ' A' ' 117' ' ' ALA . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 112' ' ' PHE . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.621 ' HA ' HD13 ' A' ' 111' ' ' ILE . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.609 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.752 ' HA ' HG12 ' A' ' 160' ' ' VAL . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' A' ' 148' ' ' ALA . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 132' ' ' VAL . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.809 ' O ' HG23 ' A' ' 146' ' ' VAL . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.882 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.893 ' O ' HG23 ' A' ' 152' ' ' THR . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 96' ' ' ILE . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' CD ' HG12 ' A' ' 146' ' ' VAL . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 148' ' ' ALA . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 152' ' ' THR . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HE3' HD11 ' A' ' 130' ' ' LEU . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 84' ' ' VAL . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 120' ' ' THR . 25.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.724 HD12 HG23 ' A' ' 96' ' ' ILE . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 149' ' ' LEU . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.809 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 127' ' ' ASP . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.767 HG12 HD12 ' A' ' 123' ' ' LEU . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' CA ' ' A' ' 93' ' ' GLY . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 84' ' ' VAL . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.767 HD12 HG12 ' A' ' 111' ' ' ILE . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.727 ' HA ' HD13 ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.897 ' HA ' HG12 ' A' ' 160' ' ' VAL . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 145' ' ' ALA . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.944 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.944 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 96' ' ' ILE . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 81' ' ' ARG . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 131' ' ' SER . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.866 0.365 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.473 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.726 ' O ' HD12 ' A' ' 158' ' ' LEU . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 120' ' ' THR . 27.8 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 111' ' ' ILE . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.798 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.696 HH11 HG23 ' A' ' 141' ' ' THR . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 104' ' ' MET . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.604 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.503 HG21 HG22 ' A' ' 84' ' ' VAL . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.663 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.638 HG13 HG12 ' A' ' 160' ' ' VAL . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 145' ' ' ALA . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.741 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.696 HG23 HH11 ' A' ' 100' ' ' ARG . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.741 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.702 ' HA ' HD11 ' A' ' 137' ' ' LEU . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.558 HD21 HD23 ' A' ' 158' ' ' LEU . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HD2' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.902 HG22 HG22 ' A' ' 156' ' ' VAL . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 152' ' ' THR . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 81' ' ' ARG . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.638 HG12 HG13 ' A' ' 129' ' ' ILE . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.876 HG23 HG22 ' A' ' 157' ' ' VAL . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.799 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.632 HG22 HD12 ' A' ' 129' ' ' ILE . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 127' ' ' ASP . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.739 HG12 HD12 ' A' ' 123' ' ' LEU . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.744 ' HB3' HD12 ' A' ' 115' ' ' LEU . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.792 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.549 ' HA ' HD13 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.862 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.585 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.807 ' HA ' HG12 ' A' ' 160' ' ' VAL . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.509 HD12 ' HG3' ' A' ' 161' ' ' LYS . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.4 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 137' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 132' ' ' VAL . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 151' ' ' LYS . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.731 ' HD3' HG12 ' A' ' 146' ' ' VAL . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 148' ' ' ALA . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.455 ' CB ' HG22 ' A' ' 156' ' ' VAL . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.819 HG12 HD23 ' A' ' 158' ' ' LEU . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 83' ' ' THR . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 131' ' ' SER . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.807 HG12 ' HA ' ' A' ' 129' ' ' ILE . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 130' ' ' LEU . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.811 0.338 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 83' ' ' THR . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 120' ' ' THR . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 116' ' ' ALA . 21.8 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.9 HG22 HG23 ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.696 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.796 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.693 HG13 HD23 ' A' ' 137' ' ' LEU . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.816 HG21 HD11 ' A' ' 111' ' ' ILE . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.9 HG23 HG22 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 112' ' ' PHE . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 123' ' ' LEU . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 83' ' ' THR . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.432 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.857 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.81 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.895 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.643 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 96' ' ' ILE . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.46 HD12 HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.81 HG12 ' HA ' ' A' ' 129' ' ' ILE . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 158' ' ' LEU . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.623 -0.191 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 111' ' ' ILE . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.591 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.812 ' HA ' HG22 ' A' ' 94' ' ' ILE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 111' ' ' ILE . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.476 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' GLY . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 160' ' ' VAL . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 161' ' ' LYS . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.665 HG11 ' HB1' ' A' ' 148' ' ' ALA . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 132' ' ' VAL . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.91 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 96' ' ' ILE . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 146' ' ' VAL . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' ALA . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 81' ' ' ARG . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 130' ' ' LEU . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG11 HD23 ' A' ' 123' ' ' LEU . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.782 HG21 ' CD1' ' A' ' 123' ' ' LEU . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 146' ' ' VAL . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.694 HD23 ' HA ' ' A' ' 128' ' ' ALA . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 127' ' ' ASP . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.754 ' HA ' HG22 ' A' ' 94' ' ' ILE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 115' ' ' LEU . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 112' ' ' PHE . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.782 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.792 HG23 ' HA ' ' A' ' 109' ' ' SER . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.694 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 106' ' ' ILE . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 HD23 ' A' ' 149' ' ' LEU . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.5 m120 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.508 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.568 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 158' ' ' LEU . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 81' ' ' ARG . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.764 HD21 HD22 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 129' ' ' ILE . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 169.99 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 123' ' ' LEU . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.04 HG11 ' HB1' ' A' ' 116' ' ' ALA . 25.9 t -126.03 135.04 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -92.04 129.65 37.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 156' ' ' VAL . 11.7 mtpt -110.16 131.42 55.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.75 -76.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.27 98.56 3.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -175.72 -64.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.12 -49.13 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.41 -94.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 HD21 HD22 ' A' ' 149' ' ' LEU . 9.2 mp -103.97 178.78 4.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -167.77 59.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.372 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 117' ' ' ALA . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.719 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.499 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 127' ' ' ASP . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 108' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' N ' HG22 ' A' ' 111' ' ' ILE . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.409 HD13 ' HA3' ' A' ' 93' ' ' GLY . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.04 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.713 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.612 ' HA ' HD13 ' A' ' 111' ' ' ILE . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HA ' HG12 ' A' ' 160' ' ' VAL . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 149' ' ' LEU . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 145' ' ' ALA . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.823 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.808 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.572 HD22 HD21 ' A' ' 92' ' ' LEU . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 86' ' ' LYS . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.43 98.31 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.8 mmm -131.44 28.35 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 151.45 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.924 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.93 160.22 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 123' ' ' LEU . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG11 ' HB1' ' A' ' 116' ' ' ALA . 30.7 t -102.66 134.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -122.85 144.98 48.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -65.55 102.86 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.51 -32.88 6.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.58 -178.83 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.796 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.08 -57.56 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 132.67 50.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.03 131.96 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD11 ' O ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER 61.02 -178.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 167.21 66.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.54 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 117' ' ' ALA . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.855 HG22 HD12 ' A' ' 129' ' ' ILE . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.724 HG21 HD11 ' A' ' 111' ' ' ILE . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 125' ' ' VAL . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.84 ' HA ' HG22 ' A' ' 94' ' ' ILE . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 115' ' ' LEU . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 109' ' ' SER . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.855 HD12 HG22 ' A' ' 106' ' ' ILE . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.917 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.861 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.917 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.635 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 142' ' ' HIS . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 158' ' ' LEU . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.855 ' HD2' HG12 ' A' ' 146' ' ' VAL . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.451 ' CB ' HG22 ' A' ' 156' ' ' VAL . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.451 HG22 ' CB ' ' A' ' 152' ' ' THR . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -69.88 103.88 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -0.99 9.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.35 -78.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.889 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.788 0.328 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -145.98 149.18 33.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.759 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 122' ' ' ALA . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 158' ' ' LEU . 21.6 t -103.52 129.98 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.01 112.15 24.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.15 85.12 6.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.74 -49.25 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -32.93 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.99 122.55 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.046 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.07 99.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.18 -179.92 18.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.66 HD21 HD21 ' A' ' 158' ' ' LEU . 6.3 mp -79.75 -75.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 111.32 59.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.646 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.69 HG22 ' HA ' ' A' ' 111' ' ' ILE . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.641 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 111' ' ' ILE . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.936 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 126' ' ' GLY . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 108' ' ' ILE . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.684 ' HA ' HG12 ' A' ' 160' ' ' VAL . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.846 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.895 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.641 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 96' ' ' ILE . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.505 ' O ' HD12 ' A' ' 158' ' ' LEU . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.66 HD21 HD21 ' A' ' 92' ' ' LEU . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -69.74 108.15 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.78 8.92 12.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.366 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 pttm 45.81 -168.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.436 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.865 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.849 0.357 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -143.17 151.46 40.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.715 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p -127.57 138.67 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.99 138.33 53.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 157.52 34.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.99 -30.96 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.99 73.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 59.86 94.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.01 88.85 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.84 157.74 17.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 158' ' ' LEU . 0.2 OUTLIER 60.84 -172.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.84 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.02 64.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.353 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 1.056 HG22 HG23 ' A' ' 111' ' ' ILE . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.718 HD13 HD12 ' A' ' 149' ' ' LEU . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.8 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 127' ' ' ASP . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 125' ' ' VAL . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.056 HG23 HG22 ' A' ' 94' ' ' ILE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.686 ' HB3' HD12 ' A' ' 115' ' ' LEU . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 112' ' ' PHE . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 109' ' ' SER . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.728 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 160' ' ' VAL . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.698 ' OD1' HG13 ' A' ' 156' ' ' VAL . 1.6 m120 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.046 HD23 ' HB3' ' A' ' 140' ' ' ALA . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.046 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.587 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 148' ' ' ALA . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.698 HG13 ' OD1' ' A' ' 133' ' ' ASN . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 92' ' ' LEU . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 129' ' ' ILE . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.85 100.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 107' ' ' LEU . 7.7 mtm -91.29 -16.68 27.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.342 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 61.34 -81.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.895 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -148.62 153.11 37.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.465 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.561 ' OG1' HG22 ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p -118.02 142.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -90.96 159.38 16.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -95.54 145.9 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -75.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -176.77 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 -31.46 7.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.57 -92.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.88 -129.64 8.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 pp -93.89 126.83 39.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.66 70.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 117' ' ' ALA . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.787 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.705 HG21 HD11 ' A' ' 111' ' ' ILE . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 123' ' ' LEU . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.818 ' O ' HD13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.595 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 160' ' ' VAL . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 130' ' ' LEU . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 137' ' ' LEU . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 132' ' ' VAL . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.81 HD21 ' HA ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.749 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.81 ' HA ' HD21 ' A' ' 137' ' ' LEU . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 HD13 ' A' ' 96' ' ' ILE . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 148' ' ' ALA . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 158' ' ' LEU . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.561 HG22 ' OG1' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.87 85.05 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 75.3 mtm -111.6 18.2 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 40.52 75.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.828 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.796 0.332 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -149.48 155.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 122' ' ' ALA . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.726 ' CG1' HD11 ' A' ' 158' ' ' LEU . 12.9 p -108.15 148.17 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.9 117.44 29.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 131.56 35.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.31 175.51 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.81 -32.14 70.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.998 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.01 91.43 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.78 152.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.603 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.72 -139.28 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.54 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.544 HD22 HD22 ' A' ' 149' ' ' LEU . 5.2 mp -68.86 -59.98 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.849 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.82 50.4 0.74 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 123' ' ' LEU . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 127' ' ' ASP . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.633 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 112' ' ' PHE . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.413 ' N ' HD11 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' A' ' 160' ' ' VAL . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 161' ' ' LYS . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 137' ' ' LEU . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 132' ' ' VAL . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.929 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.929 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.586 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 142' ' ' HIS . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD22 HD22 ' A' ' 92' ' ' LEU . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 156' ' ' VAL . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 152' ' ' THR . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.726 HD11 ' CG1' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 129' ' ' ILE . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.407 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.06 98.3 7.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -5.99 58.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.334 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.33 163.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.95 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.834 0.35 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 154.17 38.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 123' ' ' LEU . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 116' ' ' ALA . 19.9 t -108.81 142.94 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.74 133.54 35.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.051 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -164.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.42 32.73 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.76 122.91 36.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.25 121.6 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.0 -23.0 35.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.95 -73.88 2.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 94' ' ' ILE . 1.7 mm? -119.4 179.45 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.666 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -168.22 80.4 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.491 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.958 HG22 HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 127' ' ' ASP . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 115' ' ' LEU . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.666 HD13 ' HA3' ' A' ' 93' ' ' GLY . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.716 ' HA ' HG12 ' A' ' 160' ' ' VAL . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 HD23 ' A' ' 158' ' ' LEU . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.95 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.834 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.95 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 158' ' ' LEU . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 81' ' ' ARG . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.572 ' CD2' HD21 ' A' ' 149' ' ' LEU . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -69.95 100.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.6 23.42 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.069 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 59.22 161.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.971 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.781 0.324 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.91 137.35 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 123' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 120' ' ' THR . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.768 HG23 HD21 ' A' ' 158' ' ' LEU . 21.7 t -124.21 141.41 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 141.49 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -66.97 139.07 57.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 90' ' ' GLY . . . -110.26 179.1 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.145 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -48.5 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.47 81.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.063 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 108.42 129.6 6.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.37 -53.21 1.48 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 149' ' ' LEU . 53.9 mt -110.22 158.08 18.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -149.74 72.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.387 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 123' ' ' LEU . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.513 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HE ' HG23 ' A' ' 141' ' ' THR . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.941 HG21 HD11 ' A' ' 111' ' ' ILE . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.941 HD11 HG21 ' A' ' 108' ' ' ILE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 112' ' ' PHE . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.77 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 137' ' ' LEU . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.537 HG23 ' HE ' ' A' ' 100' ' ' ARG . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 152' ' ' THR . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.763 ' O ' HD11 ' A' ' 92' ' ' LEU . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.639 ' HD2' HG12 ' A' ' 146' ' ' VAL . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.694 HG21 HG13 ' A' ' 156' ' ' VAL . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.694 HG13 HG21 ' A' ' 152' ' ' THR . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.768 HD21 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 110.55 5.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 13.3 mtt -135.03 21.74 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 117.4 11.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.981 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.35 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.53 154.94 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 123' ' ' LEU . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.4 t -127.88 147.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -110.81 126.88 55.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.711 ' HE3' HG21 ' A' ' 156' ' ' VAL . 0.0 OUTLIER -74.39 171.5 13.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.74 -47.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.1 178.51 5.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.02 133.38 40.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.73 -46.84 0.67 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.02 -144.75 15.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.469 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -91.66 176.44 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.917 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -127.08 79.31 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.868 HG22 HD13 ' A' ' 108' ' ' ILE . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.788 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.622 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 96' ' ' ILE . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG12 HD12 ' A' ' 123' ' ' LEU . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 84' ' ' VAL . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.658 ' HA ' HD13 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 108' ' ' ILE . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.568 HD13 ' HD3' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.45 HG23 HD23 ' A' ' 158' ' ' LEU . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.479 ' OD1' HG13 ' A' ' 156' ' ' VAL . 2.5 m120 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 140' ' ' ALA . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.01 ' HB1' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 1.01 ' HG2' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 96' ' ' ILE . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HD3' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.711 HG21 ' HE3' ' A' ' 86' ' ' LYS . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 81' ' ' ARG . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.45 HD23 HG23 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HD3' HD13 ' A' ' 130' ' ' LEU . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.98 92.39 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.5 mtp -95.07 -4.85 45.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 166.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.847 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.953 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.697 0.284 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HB2' HG23 ' A' ' 160' ' ' VAL . 3.0 mtt180 -123.92 156.84 35.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 158' ' ' LEU . 21.9 t -123.59 136.42 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.72 148.09 28.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -135.19 31.59 3.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 169.65 3.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.04 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -174.78 175.45 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.77 -164.06 12.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.64 160.87 30.98 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.428 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 84' ' ' VAL . 87.4 mt -75.72 -176.78 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -149.54 77.47 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.589 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.651 HG23 ' HB2' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.46 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.715 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.774 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD22 ' OXT' ' A' ' 165' ' ' GLU . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.782 HD12 ' HB2' ' A' ' 127' ' ' ASP . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.782 HG12 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 111' ' ' ILE . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.514 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.782 HD12 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 125' ' ' VAL . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.622 ' CG1' HG12 ' A' ' 160' ' ' VAL . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 137' ' ' LEU . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.06 HD23 ' HB3' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 1.06 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.831 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.785 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 142' ' ' HIS . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 24.0 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.455 HD22 HD21 ' A' ' 158' ' ' LEU . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 152' ' ' THR . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 84' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -69.9 93.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.12 10.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.529 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt 55.03 27.22 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.534 ' OXT' HD22 ' A' ' 107' ' ' LEU . 2.8 tp10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.961 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.784 0.326 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.89 146.3 26.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.788 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.403 ' HB3' HG13 ' A' ' 157' ' ' VAL . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.729 HG11 HD23 ' A' ' 123' ' ' LEU . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.612 ' O ' HG21 ' A' ' 120' ' ' THR . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t -109.02 125.6 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -87.68 134.81 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -89.71 118.58 29.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.05 178.04 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -53.52 45.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 93.35 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.97 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.06 -174.57 34.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.408 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.33 119.91 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.33 75.46 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 94' ' ' ILE . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.805 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.559 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 128' ' ' ALA . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 129' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.702 ' CD1' HG21 ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 115' ' ' LEU . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 112' ' ' PHE . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' C ' HD11 ' A' ' 123' ' ' LEU . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' O ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 108' ' ' ILE . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 161' ' ' LYS . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 132' ' ' VAL . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.833 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.943 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' HIS . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 158' ' ' LEU . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 81' ' ' ARG . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 149' ' ' LEU . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 129' ' ' ILE . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.9 101.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.1 ptm -148.38 28.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.992 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 121.19 11.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.839 0.352 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -170.01 157.83 6.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 122' ' ' ALA . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 86' ' ' LYS . 21.9 t -101.34 125.88 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 112.62 25.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HG2' HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -109.65 72.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.58 -35.34 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -84.19 -174.42 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 100.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.12 -165.75 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.04 40.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 59.78 -170.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 175.46 76.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.405 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 123' ' ' LEU . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.725 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.762 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD23 ' CA ' ' A' ' 128' ' ' ALA . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.677 HD11 HG21 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 92' ' ' LEU . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.4 ' HA ' HG13 ' A' ' 111' ' ' ILE . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.67 ' OD2' HD12 ' A' ' 108' ' ' ILE . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' CA ' HD23 ' A' ' 107' ' ' LEU . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.715 ' HA ' HG12 ' A' ' 160' ' ' VAL . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.598 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.752 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.598 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 142' ' ' HIS . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 158' ' ' LEU . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 148' ' ' ALA . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 152' ' ' THR . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 149' ' ' LEU . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -106.66 106.35 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.8 mtt -109.0 -3.84 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -71.39 137.6 48.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' N ' ' HG2' ' A' ' 161' ' ' LYS . 4.9 ttp85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.743 0.306 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -150.14 153.84 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 122' ' ' ALA . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.95 140.48 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 134.01 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -86.43 171.64 10.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.82 30.12 19.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.34 -43.43 2.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -163.05 30.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.36 -167.48 23.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.44 53.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.489 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 26.6 tp 60.36 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -115.43 96.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.59 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.954 HD13 HD12 ' A' ' 149' ' ' LEU . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.575 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.888 HD12 ' HB2' ' A' ' 127' ' ' ASP . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.768 HD11 HG21 ' A' ' 108' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.74 ' HA ' HD13 ' A' ' 111' ' ' ILE . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.58 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.587 ' CG1' HG12 ' A' ' 160' ' ' VAL . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 161' ' ' LYS . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 137' ' ' LEU . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.709 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.81 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.81 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.709 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 142' ' ' HIS . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.954 HD12 HD13 ' A' ' 96' ' ' ILE . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.6 HG21 HG22 ' A' ' 156' ' ' VAL . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 152' ' ' THR . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 149' ' ' LEU . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.599 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.79 99.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mmt -110.86 -3.93 15.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.468 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -43.62 6.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 156.31 6.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 123' ' ' LEU . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.5 t -101.91 135.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 143.4 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -71.59 81.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.24 95.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.057 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.15 -79.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.8 115.35 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.9 107.95 0.25 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.437 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.48 -76.03 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.504 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.95 160.77 39.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.786 0.327 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -160.83 72.4 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.656 HG22 HG23 ' A' ' 111' ' ' ILE . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.687 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.802 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 125' ' ' VAL . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.685 HG23 ' HB1' ' A' ' 117' ' ' ALA . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 112' ' ' PHE . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.621 ' HA ' HD13 ' A' ' 111' ' ' ILE . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.609 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.752 ' HA ' HG12 ' A' ' 160' ' ' VAL . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' A' ' 148' ' ' ALA . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 132' ' ' VAL . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.809 ' O ' HG23 ' A' ' 146' ' ' VAL . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.882 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.893 ' O ' HG23 ' A' ' 152' ' ' THR . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 96' ' ' ILE . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' CD ' HG12 ' A' ' 146' ' ' VAL . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 148' ' ' ALA . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 152' ' ' THR . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HE3' HD11 ' A' ' 130' ' ' LEU . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -70.01 101.47 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.21 -8.17 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.394 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 tttt 63.2 133.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.879 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -159.15 145.89 16.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.769 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 84' ' ' VAL . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 120' ' ' THR . 25.5 t -100.47 128.49 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -86.45 130.11 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.72 163.34 17.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.13 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -167.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 62.2 178.87 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.78 -60.07 5.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.63 -104.11 0.66 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.88 -64.55 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 125.06 58.61 0.17 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.724 HD12 HG23 ' A' ' 96' ' ' ILE . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 149' ' ' LEU . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.809 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 127' ' ' ASP . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.767 HG12 HD12 ' A' ' 123' ' ' LEU . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' CA ' ' A' ' 93' ' ' GLY . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 84' ' ' VAL . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.767 HD12 HG12 ' A' ' 111' ' ' ILE . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.727 ' HA ' HD13 ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.897 ' HA ' HG12 ' A' ' 160' ' ' VAL . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 145' ' ' ALA . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.944 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.944 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 96' ' ' ILE . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 81' ' ' ARG . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 131' ' ' SER . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 95.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.5 mtt -124.84 23.57 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.183 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.39 111.21 12.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.881 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.29 149.79 27.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.473 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.726 ' O ' HD12 ' A' ' 158' ' ' LEU . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 120' ' ' THR . 27.8 t -123.8 125.13 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.08 138.6 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -71.69 -179.57 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 -69.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.8 -66.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.2 -52.69 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.58 153.85 46.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.73 82.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp 59.9 109.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -141.46 82.27 0.23 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.492 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 111' ' ' ILE . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.798 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.696 HH11 HG23 ' A' ' 141' ' ' THR . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 104' ' ' MET . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.604 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.503 HG21 HG22 ' A' ' 84' ' ' VAL . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.663 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.638 HG13 HG12 ' A' ' 160' ' ' VAL . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 145' ' ' ALA . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.741 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.696 HG23 HH11 ' A' ' 100' ' ' ARG . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.741 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.702 ' HA ' HD11 ' A' ' 137' ' ' LEU . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.558 HD21 HD23 ' A' ' 158' ' ' LEU . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HD2' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.902 HG22 HG22 ' A' ' 156' ' ' VAL . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 152' ' ' THR . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 81' ' ' ARG . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.638 HG12 HG13 ' A' ' 129' ' ' ILE . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -69.71 109.48 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.36 2.0 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.251 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 131.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.935 0.398 . . . . 0.0 110.959 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.925 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.83 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.876 HG23 HG22 ' A' ' 157' ' ' VAL . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.53 143.7 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -116.89 143.17 46.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.14 166.91 23.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.74 -174.63 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.94 -30.81 66.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.15 130.65 56.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.53 -155.38 33.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.3 157.22 33.2 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 tp 62.13 150.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 176.22 69.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.545 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.799 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.632 HG22 HD12 ' A' ' 129' ' ' ILE . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 127' ' ' ASP . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.739 HG12 HD12 ' A' ' 123' ' ' LEU . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.744 ' HB3' HD12 ' A' ' 115' ' ' LEU . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.792 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.549 ' HA ' HD13 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.862 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.585 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.807 ' HA ' HG12 ' A' ' 160' ' ' VAL . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD12 ' HG3' ' A' ' 161' ' ' LYS . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.4 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 137' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 132' ' ' VAL . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' HA ' ' HG2' ' A' ' 151' ' ' LYS . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.731 ' HD3' HG12 ' A' ' 146' ' ' VAL . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 148' ' ' ALA . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.455 ' CB ' HG22 ' A' ' 156' ' ' VAL . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.819 HG12 HD23 ' A' ' 158' ' ' LEU . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 83' ' ' THR . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 131' ' ' SER . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.807 HG12 ' HA ' ' A' ' 129' ' ' ILE . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 130' ' ' LEU . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.86 116.95 10.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mtp -117.47 -4.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.319 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 61.57 156.18 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.865 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.856 0.36 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -158.23 164.85 36.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 83' ' ' THR . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 120' ' ' THR . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 116' ' ' ALA . 21.8 t -130.87 130.57 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.99 162.3 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 88.91 3.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.25 171.57 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -65.9 -31.73 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.76 33.12 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.01 179.0 51.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 116' ' ' ALA . . . -116.22 -169.38 15.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 149' ' ' LEU . 7.9 mt 59.38 -179.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 132.78 66.94 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.513 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.9 HG22 HG23 ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.696 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.796 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.693 HG13 HD23 ' A' ' 137' ' ' LEU . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.816 HG21 HD11 ' A' ' 111' ' ' ILE . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.9 HG23 HG22 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 112' ' ' PHE . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.665 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 123' ' ' LEU . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 83' ' ' THR . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.432 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.857 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.81 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.895 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.643 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 96' ' ' ILE . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.46 HD12 HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.81 HG12 ' HA ' ' A' ' 129' ' ' ILE . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -69.95 110.03 4.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.6 mmt -145.14 28.13 1.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -140.58 158.93 43.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.887 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.807 0.337 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.22 142.19 7.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.795 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 158' ' ' LEU . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t -103.8 141.45 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.65 114.21 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -91.42 72.29 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.41 -70.68 0.3 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -143.17 -56.18 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.822 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.81 115.25 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.62 ' CA ' ' HB2' ' A' ' 116' ' ' ALA . . . 103.35 112.47 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.52 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.672 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -140.11 86.63 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.575 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER 45.64 -168.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.755 0.312 . . . . 0.0 111.425 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 143.05 77.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.623 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 111' ' ' ILE . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.591 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.812 ' HA ' HG22 ' A' ' 94' ' ' ILE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 111' ' ' ILE . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.476 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' GLY . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 160' ' ' VAL . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 161' ' ' LYS . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.665 HG11 ' HB1' ' A' ' 148' ' ' ALA . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 132' ' ' VAL . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.91 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 96' ' ' ILE . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 146' ' ' VAL . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' ALA . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 81' ' ' ARG . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 130' ' ' LEU . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.93 100.86 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.5 mtt -112.55 -5.89 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.37 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 170.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.727 0.298 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 163.75 27.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG11 HD23 ' A' ' 123' ' ' LEU . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.51 140.1 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 120.62 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.27 79.31 4.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 37.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.056 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.428 ' OD2' ' NE2' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -128.17 23.95 5.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.076 179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 53.82 29.42 9.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.571 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 116' ' ' ALA . . . 127.84 -120.7 3.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.434 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' H ' HD23 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -106.11 147.29 29.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.993 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -138.99 84.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.441 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.782 HG21 ' CD1' ' A' ' 123' ' ' LEU . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 146' ' ' VAL . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.694 HD23 ' HA ' ' A' ' 128' ' ' ALA . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 127' ' ' ASP . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.754 ' HA ' HG22 ' A' ' 94' ' ' ILE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 115' ' ' LEU . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 112' ' ' PHE . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 91' ' ' GLY . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.428 ' NE2' ' OD2' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.782 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.792 HG23 ' HA ' ' A' ' 109' ' ' SER . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.694 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 106' ' ' ILE . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG11 HD23 ' A' ' 149' ' ' LEU . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 24.5 m120 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.508 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.568 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 158' ' ' LEU . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 81' ' ' ARG . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.764 HD21 HD22 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 129' ' ' ILE . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -70.64 108.28 4.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.84 27.98 6.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.014 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? 68.33 -68.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.86 0.362 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 123' ' ' LEU . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.04 HG11 ' HB1' ' A' ' 116' ' ' ALA . 25.9 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 117' ' ' ALA . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.719 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.499 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 127' ' ' ASP . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 108' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' N ' HG22 ' A' ' 111' ' ' ILE . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.409 HD13 ' HA3' ' A' ' 93' ' ' GLY . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 1.04 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.713 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.612 ' HA ' HD13 ' A' ' 111' ' ' ILE . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HA ' HG12 ' A' ' 160' ' ' VAL . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 149' ' ' LEU . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 145' ' ' ALA . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.823 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.808 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.503 HD12 ' CD1' ' A' ' 96' ' ' ILE . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.83 0.348 . . . . 0.0 110.899 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 123' ' ' LEU . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.539 HG11 ' HB1' ' A' ' 116' ' ' ALA . 30.7 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 117' ' ' ALA . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.855 HG22 HD12 ' A' ' 129' ' ' ILE . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.724 HG21 HD11 ' A' ' 111' ' ' ILE . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 125' ' ' VAL . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.84 ' HA ' HG22 ' A' ' 94' ' ' ILE . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 115' ' ' LEU . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 109' ' ' SER . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.855 HD12 HG22 ' A' ' 106' ' ' ILE . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.917 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.861 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.917 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.635 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 142' ' ' HIS . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 158' ' ' LEU . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.855 ' HD2' HG12 ' A' ' 146' ' ' VAL . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.451 ' CB ' HG22 ' A' ' 156' ' ' VAL . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.451 HG22 ' CB ' ' A' ' 152' ' ' THR . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.795 0.331 . . . . 0.0 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 122' ' ' ALA . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 158' ' ' LEU . 21.6 t . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.69 HG22 ' HA ' ' A' ' 111' ' ' ILE . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.641 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 111' ' ' ILE . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.936 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 126' ' ' GLY . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 108' ' ' ILE . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.684 ' HA ' HG12 ' A' ' 160' ' ' VAL . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.846 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.895 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.641 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 96' ' ' ILE . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.505 ' O ' HD12 ' A' ' 158' ' ' LEU . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 156' ' ' VAL . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.715 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.353 -0.299 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 1.056 HG22 HG23 ' A' ' 111' ' ' ILE . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.718 HD13 HD12 ' A' ' 149' ' ' LEU . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.8 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 127' ' ' ASP . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 125' ' ' VAL . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.056 HG23 HG22 ' A' ' 94' ' ' ILE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.686 ' HB3' HD12 ' A' ' 115' ' ' LEU . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 112' ' ' PHE . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 109' ' ' SER . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.728 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 160' ' ' VAL . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.848 ' ND2' HG13 ' A' ' 156' ' ' VAL . 2.2 m-80 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.046 HD23 ' HB3' ' A' ' 140' ' ' ALA . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.046 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.587 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 148' ' ' ALA . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.848 HG13 ' ND2' ' A' ' 133' ' ' ASN . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 129' ' ' ILE . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.77 0.319 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.465 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.561 ' OG1' HG22 ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.366 -0.294 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 117' ' ' ALA . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.787 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.705 HG21 HD11 ' A' ' 111' ' ' ILE . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 123' ' ' LEU . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.818 ' O ' HD13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.595 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 160' ' ' VAL . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 130' ' ' LEU . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 137' ' ' LEU . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 132' ' ' VAL . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.81 HD21 ' HA ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.749 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.81 ' HA ' HD21 ' A' ' 137' ' ' LEU . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 HD13 ' A' ' 96' ' ' ILE . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 148' ' ' ALA . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 158' ' ' LEU . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.561 HG22 ' OG1' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.666 0.27 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 122' ' ' ALA . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.726 ' CG1' HD11 ' A' ' 158' ' ' LEU . 12.9 p . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 123' ' ' LEU . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 127' ' ' ASP . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.633 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 112' ' ' PHE . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.413 ' N ' HD11 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' A' ' 160' ' ' VAL . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 161' ' ' LYS . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 137' ' ' LEU . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 132' ' ' VAL . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.929 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.929 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.586 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 142' ' ' HIS . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.438 HD12 ' CD1' ' A' ' 96' ' ' ILE . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 156' ' ' VAL . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 152' ' ' THR . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.726 HD11 ' CG1' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 129' ' ' ILE . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.407 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.795 0.331 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 123' ' ' LEU . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 116' ' ' ALA . 19.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.666 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.958 HG22 HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 127' ' ' ASP . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 115' ' ' LEU . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.666 HD13 ' HA3' ' A' ' 93' ' ' GLY . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.716 ' HA ' HG12 ' A' ' 160' ' ' VAL . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 HD23 ' A' ' 158' ' ' LEU . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.95 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.834 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.95 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 158' ' ' LEU . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 81' ' ' ARG . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.572 ' CD2' HD21 ' A' ' 149' ' ' LEU . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.78 0.324 . . . . 0.0 110.727 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 123' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 120' ' ' THR . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.768 HG23 HD21 ' A' ' 158' ' ' LEU . 21.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.387 -0.285 . . . . 0.0 112.387 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 123' ' ' LEU . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.513 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HE ' HG23 ' A' ' 141' ' ' THR . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.941 HG21 HD11 ' A' ' 111' ' ' ILE . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.941 HD11 HG21 ' A' ' 108' ' ' ILE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 112' ' ' PHE . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.77 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 137' ' ' LEU . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.537 HG23 ' HE ' ' A' ' 100' ' ' ARG . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 152' ' ' THR . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 96' ' ' ILE . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.639 ' HD2' HG12 ' A' ' 146' ' ' VAL . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.694 HG21 HG13 ' A' ' 156' ' ' VAL . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.694 HG13 HG21 ' A' ' 152' ' ' THR . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.768 HD21 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 123' ' ' LEU . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.868 HG22 HD13 ' A' ' 108' ' ' ILE . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.788 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.622 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 96' ' ' ILE . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.763 HG12 HD12 ' A' ' 123' ' ' LEU . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 84' ' ' VAL . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.658 ' HA ' HD13 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 108' ' ' ILE . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.568 HD13 ' HD3' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG22 HD22 ' A' ' 133' ' ' ASN . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.687 HD21 HG13 ' A' ' 156' ' ' VAL . 2.6 m-80 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 140' ' ' ALA . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.01 ' HB1' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 1.01 ' HG2' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 96' ' ' ILE . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HD3' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.687 HG13 HD21 ' A' ' 133' ' ' ASN . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 81' ' ' ARG . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.45 HD23 HG23 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HD3' HD13 ' A' ' 130' ' ' LEU . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HB2' HG23 ' A' ' 160' ' ' VAL . 3.0 mtt180 . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 158' ' ' LEU . 21.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.589 -0.204 . . . . 0.0 112.589 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.651 HG23 ' HB2' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.46 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.715 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.774 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.782 HD12 ' HB2' ' A' ' 127' ' ' ASP . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.782 HG12 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 111' ' ' ILE . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.514 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.782 HD12 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.622 ' CG1' HG12 ' A' ' 160' ' ' VAL . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 137' ' ' LEU . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 1.06 HD23 ' HB3' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 1.06 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.831 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.785 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 142' ' ' HIS . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 43.4 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.455 HD22 HD21 ' A' ' 158' ' ' LEU . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 152' ' ' THR . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 84' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 120.796 0.331 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.403 ' HB3' HG13 ' A' ' 157' ' ' VAL . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.729 HG11 HD23 ' A' ' 123' ' ' LEU . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.612 ' O ' HG21 ' A' ' 120' ' ' THR . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 94' ' ' ILE . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.805 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.559 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 128' ' ' ALA . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 129' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.702 ' CD1' HG21 ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 115' ' ' LEU . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 112' ' ' PHE . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' C ' HD11 ' A' ' 123' ' ' LEU . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' O ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 108' ' ' ILE . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 161' ' ' LYS . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 132' ' ' VAL . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.833 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.943 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' HIS . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 158' ' ' LEU . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 81' ' ' ARG . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 149' ' ' LEU . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 129' ' ' ILE . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.797 0.332 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 122' ' ' ALA . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.405 -0.278 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 123' ' ' LEU . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.725 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.762 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.539 HD23 ' CA ' ' A' ' 128' ' ' ALA . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.677 HD11 HG21 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 112' ' ' PHE . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.4 ' HA ' HG13 ' A' ' 111' ' ' ILE . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.67 ' OD2' HD12 ' A' ' 108' ' ' ILE . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.539 ' CA ' HD23 ' A' ' 107' ' ' LEU . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.715 ' HA ' HG12 ' A' ' 160' ' ' VAL . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.595 HD22 HG22 ' A' ' 152' ' ' THR . 3.7 t-20 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.598 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.752 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.598 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 142' ' ' HIS . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 158' ' ' LEU . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 148' ' ' ALA . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 152' ' ' THR . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 149' ' ' LEU . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.943 0.401 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 122' ' ' ALA . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.954 HD13 HD12 ' A' ' 149' ' ' LEU . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.575 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.888 HD12 ' HB2' ' A' ' 127' ' ' ASP . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.768 HD11 HG21 ' A' ' 108' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.74 ' HA ' HD13 ' A' ' 111' ' ' ILE . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.58 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.587 ' CG1' HG12 ' A' ' 160' ' ' VAL . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 161' ' ' LYS . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 137' ' ' LEU . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.709 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.81 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.81 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.709 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 142' ' ' HIS . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.954 HD12 HD13 ' A' ' 96' ' ' ILE . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.6 HG21 HG22 ' A' ' 156' ' ' VAL . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 152' ' ' THR . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 149' ' ' LEU . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.587 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.599 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.842 0.353 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 123' ' ' LEU . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.5 t . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.656 HG22 HG23 ' A' ' 111' ' ' ILE . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.687 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.802 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 125' ' ' VAL . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.685 HG23 ' HB1' ' A' ' 117' ' ' ALA . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 112' ' ' PHE . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.621 ' HA ' HD13 ' A' ' 111' ' ' ILE . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.609 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.752 ' HA ' HG12 ' A' ' 160' ' ' VAL . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' A' ' 148' ' ' ALA . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 132' ' ' VAL . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.809 ' O ' HG23 ' A' ' 146' ' ' VAL . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.882 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.893 ' O ' HG23 ' A' ' 152' ' ' THR . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 96' ' ' ILE . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' CD ' HG12 ' A' ' 146' ' ' VAL . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 148' ' ' ALA . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 152' ' ' THR . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HE3' HD11 ' A' ' 130' ' ' LEU . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.838 0.352 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 84' ' ' VAL . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 120' ' ' THR . 25.5 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.243 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.724 HD12 HG23 ' A' ' 96' ' ' ILE . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 149' ' ' LEU . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.809 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 127' ' ' ASP . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.767 HG12 HD12 ' A' ' 123' ' ' LEU . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' CA ' ' A' ' 93' ' ' GLY . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 84' ' ' VAL . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.767 HD12 HG12 ' A' ' 111' ' ' ILE . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.727 ' HA ' HD13 ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.897 ' HA ' HG12 ' A' ' 160' ' ' VAL . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 145' ' ' ALA . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.944 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.944 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 96' ' ' ILE . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 81' ' ' ARG . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 131' ' ' SER . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.866 0.365 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.473 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.726 ' O ' HD12 ' A' ' 158' ' ' LEU . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 120' ' ' THR . 27.8 t . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 111' ' ' ILE . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.798 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.696 HH11 HG23 ' A' ' 141' ' ' THR . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 104' ' ' MET . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.604 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.503 HG21 HG22 ' A' ' 84' ' ' VAL . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.663 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.638 HG13 HG12 ' A' ' 160' ' ' VAL . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.632 HG12 HD22 ' A' ' 133' ' ' ASN . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.632 HD22 HG12 ' A' ' 132' ' ' VAL . 13.7 p30 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 145' ' ' ALA . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.741 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.696 HG23 HH11 ' A' ' 100' ' ' ARG . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.741 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.702 ' HA ' HD11 ' A' ' 137' ' ' LEU . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.558 HD21 HD23 ' A' ' 158' ' ' LEU . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HD2' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.902 HG22 HG22 ' A' ' 156' ' ' VAL . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 152' ' ' THR . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 81' ' ' ARG . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.638 HG12 HG13 ' A' ' 129' ' ' ILE . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.876 HG23 HG22 ' A' ' 157' ' ' VAL . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.799 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.632 HG22 HD12 ' A' ' 129' ' ' ILE . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 127' ' ' ASP . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.739 HG12 HD12 ' A' ' 123' ' ' LEU . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.744 ' HB3' HD12 ' A' ' 115' ' ' LEU . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.792 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.549 ' HA ' HD13 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.862 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.585 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.807 ' HA ' HG12 ' A' ' 160' ' ' VAL . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.509 HD12 ' HG3' ' A' ' 161' ' ' LYS . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.4 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 137' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.592 HD22 HG22 ' A' ' 152' ' ' THR . 3.8 t-20 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 132' ' ' VAL . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.731 ' HD3' HG12 ' A' ' 146' ' ' VAL . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 148' ' ' ALA . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.592 HG22 HD22 ' A' ' 133' ' ' ASN . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.819 HG12 HD23 ' A' ' 158' ' ' LEU . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 83' ' ' THR . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 131' ' ' SER . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.807 HG12 ' HA ' ' A' ' 129' ' ' ILE . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 130' ' ' LEU . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.811 0.338 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 83' ' ' THR . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 120' ' ' THR . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 116' ' ' ALA . 21.8 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.9 HG22 HG23 ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.696 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.796 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.693 HG13 HD23 ' A' ' 137' ' ' LEU . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.816 HG21 HD11 ' A' ' 111' ' ' ILE . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.9 HG23 HG22 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 112' ' ' PHE . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 123' ' ' LEU . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 83' ' ' THR . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.432 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.857 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.81 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.895 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.643 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 96' ' ' ILE . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.46 HD12 HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.81 HG12 ' HA ' ' A' ' 129' ' ' ILE . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.779 0.323 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 158' ' ' LEU . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.623 -0.191 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 111' ' ' ILE . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.591 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.812 ' HA ' HG22 ' A' ' 94' ' ' ILE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 111' ' ' ILE . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.476 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' GLY . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 160' ' ' VAL . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 161' ' ' LYS . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.665 HG11 ' HB1' ' A' ' 148' ' ' ALA . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 132' ' ' VAL . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.91 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 96' ' ' ILE . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 146' ' ' VAL . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' ALA . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 81' ' ' ARG . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 130' ' ' LEU . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.819 0.342 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG11 HD23 ' A' ' 123' ' ' LEU . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 94' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.441 -0.264 . . . . 0.0 112.441 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.782 HG21 ' CD1' ' A' ' 123' ' ' LEU . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 146' ' ' VAL . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.694 HD23 ' HA ' ' A' ' 128' ' ' ALA . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 127' ' ' ASP . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.754 ' HA ' HG22 ' A' ' 94' ' ' ILE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 115' ' ' LEU . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 112' ' ' PHE . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.782 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.792 HG23 ' HA ' ' A' ' 109' ' ' SER . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.694 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 106' ' ' ILE . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' ND2' ' A' ' 133' ' ' ASN . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' A' ' 132' ' ' VAL . 65.4 m-80 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.508 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.568 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 158' ' ' LEU . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 81' ' ' ARG . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.764 HD21 HD22 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 129' ' ' ILE . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.779 0.323 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 169.99 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.891 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -98.41 120.15 38.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD23 ' A' ' 123' ' ' LEU . 19.0 t -97.44 95.95 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.103 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 39.9 m -85.17 128.74 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.04 HG11 ' HB1' ' A' ' 116' ' ' ALA . 25.9 t -126.03 135.04 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.9 mtp-105 -92.04 129.65 37.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.992 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.497 ' HD2' HG21 ' A' ' 156' ' ' VAL . 11.7 mtpt -110.16 131.42 55.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.85 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.75 -76.88 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.103 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -138.27 98.56 3.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.905 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -175.72 -64.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.12 -49.13 0.1 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.479 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.41 -94.46 0.19 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.535 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 HD21 HD22 ' A' ' 149' ' ' LEU . 9.2 mp -103.97 178.78 4.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 110.837 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.409 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -167.77 59.84 0.21 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.372 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.713 HG23 ' HB2' ' A' ' 117' ' ' ALA . 9.2 pt -147.01 154.43 11.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 111.157 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.8 t -103.26 104.64 14.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.947 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.719 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.0 pt -94.81 170.14 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.376 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.07 136.07 4.81 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.604 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.15 170.82 43.18 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.345 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.97 90.97 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.518 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.37 -27.58 24.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.834 0.35 . . . . 0.0 110.873 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.64 -42.14 87.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.385 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -90.9 13.8 15.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.726 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 63.75 31.55 14.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.828 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 ttp -116.68 118.09 37.17 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.006 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.84 156.11 63.97 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.323 2.016 . . . . 0.0 111.887 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.499 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -60.37 141.77 16.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.867 0.365 . . . . 0.0 111.115 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.1 mt -144.36 170.3 16.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.197 0.522 . . . . 0.0 112.289 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 127' ' ' ASP . 57.4 mt -92.17 134.96 28.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.541 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -129.54 -10.1 4.56 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.8 OUTLIER -172.43 89.74 0.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.481 -0.487 . . . . 0.0 112.205 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 108' ' ' ILE . 2.9 mp -76.16 156.68 5.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.237 178.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' N ' HG22 ' A' ' 111' ' ' ILE . 7.0 m-85 -119.4 163.39 17.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.983 0.42 . . . . 0.0 111.333 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.42 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 25.0 mttp -102.84 173.01 6.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.918 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 56.52 24.44 46.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.588 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.409 HD13 ' HA3' ' A' ' 93' ' ' GLY . 65.7 mt -136.54 -175.62 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.814 0.34 . . . . 0.0 110.815 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.04 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -40.92 69.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.249 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.713 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -53.75 -56.74 14.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.042 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 37.6 t70 -74.09 -9.87 59.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -75.33 -38.19 60.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.567 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.33 -15.98 36.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.276 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 46.84 46.28 15.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.39 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.95 61.76 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -173.21 97.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.047 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.612 ' HA ' HD13 ' A' ' 111' ' ' ILE . 9.1 m-85 -114.53 152.91 30.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.6 t -47.72 117.41 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.363 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 137.36 -13.54 3.75 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.626 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.857 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -78.84 144.07 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.839 0.352 . . . . 0.0 110.816 179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -107.59 108.73 20.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.308 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.644 ' HA ' HG12 ' A' ' 160' ' ' VAL . 12.1 mt -72.58 95.37 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.885 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.13 -7.68 32.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.516 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.4 m -165.29 153.27 11.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 0.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 149' ' ' LEU . 24.6 t -153.67 127.72 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.2 t30 58.39 34.06 23.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.045 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.26 22.33 68.19 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.692 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -113.64 156.67 23.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.825 0.345 . . . . 0.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 108.7 20.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.063 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.7 HD21 ' CB ' ' A' ' 145' ' ' ALA . 3.0 tp -89.23 8.52 29.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.174 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -72.77 -9.92 59.2 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.745 0.307 . . . . 0.0 111.026 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -140.98 59.59 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.153 0.501 . . . . 0.0 109.785 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.808 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -159.51 99.1 1.43 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.59 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 41.6 p -37.63 160.53 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.306 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.823 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.2 t-80 -48.25 -27.63 2.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.75 -25.04 58.82 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.959 0.409 . . . . 0.0 110.975 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.808 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.8 mm-40 -83.92 -24.77 30.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.313 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.7 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -82.63 -38.43 23.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.823 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.3 t -74.93 -31.87 26.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.361 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.455 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -79.66 -30.39 41.2 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.855 178.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.39 -24.84 50.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.547 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.572 HD22 HD21 ' A' ' 92' ' ' LEU . 55.0 mt -89.89 -25.49 20.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.066 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.406 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -90.11 -21.19 22.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.235 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -102.64 58.16 0.79 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.53 162.14 37.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.823 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -147.9 169.26 28.7 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.531 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 47.0 tttt 60.29 -138.84 0.63 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.96 130.75 43.06 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.851 0.358 . . . . 0.0 110.818 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.497 HG21 ' HD2' ' A' ' 86' ' ' LYS . 21.6 t -120.04 106.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.133 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.16 93.77 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.129 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.27 90.93 7.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.008 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.42 112.06 13.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.597 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.644 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -127.65 163.56 30.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.286 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 20.8 pttp -131.47 123.61 28.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.804 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.43 98.31 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 2.8 mmm -131.44 28.35 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 151.45 39.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.924 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.93 160.22 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.899 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.06 124.71 52.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.824 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 HD23 ' A' ' 123' ' ' LEU . 14.3 t -97.14 81.49 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 m -70.0 103.96 2.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.035 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.539 HG11 ' HB1' ' A' ' 116' ' ' ALA . 30.7 t -102.66 134.66 42.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.04 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -122.85 144.98 48.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.86 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -65.55 102.86 0.76 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -110.51 -32.88 6.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -110.58 -178.83 3.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.796 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.08 -57.56 5.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.081 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.13 132.67 50.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -94.03 131.96 10.97 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.643 HD11 ' O ' ' A' ' 149' ' ' LEU . 0.2 OUTLIER 61.02 -178.04 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 167.21 66.41 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.54 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.85 HG23 ' HB2' ' A' ' 117' ' ' ALA . 2.3 pt -161.91 157.36 2.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.339 . . . . 0.0 111.08 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -114.5 116.02 28.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.698 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.2 pt -111.58 170.23 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.964 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 3.9 mttt -163.61 139.89 6.8 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.862 0.363 . . . . 0.0 110.599 178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -168.96 170.48 42.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.554 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -167.15 87.61 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.509 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -30.7 63.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.859 0.361 . . . . 0.0 110.798 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -62.49 -38.65 90.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.285 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -90.56 9.16 30.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.797 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 70.03 30.46 3.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.963 0.411 . . . . 0.0 110.418 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.2 mtp -116.58 113.36 40.55 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.081 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.53 150.54 69.74 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.391 2.06 . . . . 0.0 111.843 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.855 HG22 HD12 ' A' ' 129' ' ' ILE . 2.8 mm -59.03 137.8 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.943 0.402 . . . . 0.0 111.346 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -144.43 170.24 16.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.281 0.562 . . . . 0.0 112.265 -178.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.724 HG21 HD11 ' A' ' 111' ' ' ILE . 4.9 mp -94.02 143.78 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.437 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG13 ' A' ' 125' ' ' VAL . 5.2 m -138.27 -5.27 1.64 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 2.1 tttt -171.17 89.86 0.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.133 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.84 ' HA ' HG22 ' A' ' 94' ' ' ILE . 2.2 mp -79.64 150.38 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.254 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.415 ' HB3' HD12 ' A' ' 115' ' ' LEU . 6.5 m-85 -104.71 153.0 21.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.999 0.428 . . . . 0.0 111.432 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -101.97 139.56 37.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.764 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.49 -8.61 74.1 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.83 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.5 mt -103.08 -175.19 2.73 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.752 0.31 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -49.92 -39.11 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.463 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.85 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.46 -43.88 79.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.085 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -83.86 -10.65 57.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.6 mm100 -74.44 -45.31 47.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.904 0.383 . . . . 0.0 110.571 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -85.29 -23.45 28.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.083 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 43.99 48.97 7.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.378 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.528 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -139.57 29.52 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.778 HD11 HG21 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -151.59 96.73 2.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.006 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.66 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.9 m-85 -104.36 155.59 18.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.1 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 109' ' ' SER . 34.7 t -52.92 137.41 13.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.278 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.53 -0.13 53.15 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.808 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.606 ' HB3' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -82.82 140.03 33.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.843 0.354 . . . . 0.0 110.761 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.519 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -96.99 107.64 20.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.286 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.855 HD12 HG22 ' A' ' 106' ' ' ILE . 39.2 mt -69.98 88.61 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.704 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.6 mt -71.67 -19.58 62.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.542 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 26.4 p -174.75 162.99 3.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.169 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -144.55 129.15 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.64 29.63 17.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.3 27.52 55.16 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.461 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -118.95 124.21 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.913 0.387 . . . . 0.0 111.004 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.78 109.47 3.87 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.971 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.46 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.1 tp -86.94 6.83 30.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.157 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 28.4 t -63.06 -17.36 62.18 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.078 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 10.0 m -139.04 59.26 1.62 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.267 0.556 . . . . 0.0 109.776 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.917 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -154.91 96.57 1.87 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.624 -179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.403 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -39.73 163.15 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.221 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.861 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.6 t-80 -48.15 -26.97 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.43 -26.68 61.05 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.036 0.446 . . . . 0.0 111.005 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.917 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 5.4 mm-40 -80.71 -27.15 37.04 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.035 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.635 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.28 -43.56 27.75 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.627 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.861 HG23 ' O ' ' A' ' 142' ' ' HIS . 24.5 t -70.96 -27.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.078 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.62 -31.39 52.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.826 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.85 -34.03 71.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.955 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 158' ' ' LEU . 4.4 mt -83.5 -24.13 31.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.674 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.855 ' HD2' HG12 ' A' ' 146' ' ' VAL . 19.5 mttp -90.09 -12.83 37.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.247 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.2 38.66 1.62 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.003 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.451 ' CB ' HG22 ' A' ' 156' ' ' VAL . 8.6 p -128.51 178.92 5.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.893 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 175.78 -34.33 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.8 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.5 -23.17 16.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.957 0.408 . . . . 0.0 111.415 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -170.34 144.75 2.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.936 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.451 HG22 ' CB ' ' A' ' 152' ' ' THR . 17.8 t -138.75 85.13 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.214 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.5 81.88 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.877 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.061 HD21 HD21 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -76.65 91.87 3.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.175 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -80.03 114.03 18.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.364 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -129.62 170.07 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.483 -179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.05 105.88 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.546 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -69.88 103.88 2.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.807 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -0.99 9.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.381 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.35 -78.37 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.789 0.328 . . . . 0.0 110.923 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.889 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.788 0.328 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -145.98 149.18 33.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.759 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 120.17 37.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.167 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 122' ' ' ALA . 24.3 t -98.87 146.63 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.552 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 40.3 m -119.69 112.36 19.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.906 0.384 . . . . 0.0 111.031 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 HD13 ' A' ' 158' ' ' LEU . 21.6 t -103.52 129.98 54.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -108.01 112.15 24.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.912 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.15 85.12 6.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.888 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.74 -49.25 1.37 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.079 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -32.93 30.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -132.99 122.55 24.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.046 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -64.07 99.11 0.29 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.18 -179.92 18.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.447 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.66 HD21 HD21 ' A' ' 158' ' ' LEU . 6.3 mp -79.75 -75.77 0.24 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.772 0.32 . . . . 0.0 110.881 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.563 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 111.32 59.18 0.47 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.646 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.69 HG22 ' HA ' ' A' ' 111' ' ' ILE . 11.5 pt -160.88 156.61 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.742 0.306 . . . . 0.0 110.927 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB2' ' CB ' ' A' ' 110' ' ' LYS . 6.9 m -106.51 118.81 37.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.063 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.691 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.3 pt -109.98 170.39 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.153 -179.251 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.54 138.0 6.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.925 0.393 . . . . 0.0 110.589 178.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.15 170.75 43.12 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.227 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.12 91.6 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.496 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -25.29 28.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 0.0 110.769 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -56.81 -48.23 78.44 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.564 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' OD1' ' CB ' ' A' ' 104' ' ' MET . 4.0 p30 -90.92 16.72 8.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 9.0 mmtt 65.18 31.89 10.52 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.264 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.406 ' CB ' ' OD1' ' A' ' 102' ' ' ASN . 22.4 ttt -111.01 115.78 52.51 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.958 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.92 152.02 68.36 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.393 2.062 . . . . 0.0 111.889 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.641 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.88 139.66 19.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 0.0 111.268 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.36 170.2 16.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.203 -178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.936 HG21 HD11 ' A' ' 111' ' ' ILE . 47.5 mt -95.31 141.0 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.692 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.31 -6.92 2.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' CB ' ' HB2' ' A' ' 95' ' ' SER . 2.8 tttt -165.87 88.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.456 -0.498 . . . . 0.0 112.024 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.936 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -73.18 121.55 24.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.678 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.35 166.49 13.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.945 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -119.11 159.98 22.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.101 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.84 75.92 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.906 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -111.46 174.96 5.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.832 0.348 . . . . 0.0 111.073 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.41 -27.42 15.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.223 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.694 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -56.24 -63.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.33 -10.97 60.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.194 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -76.59 -30.96 57.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -16.06 33.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.394 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 46.84 29.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.332 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -128.98 42.83 3.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.124 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.694 HD11 ' HB1' ' A' ' 117' ' ' ALA . 2.4 pp -172.17 105.42 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.811 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.465 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.9 m-85 -125.59 166.74 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.286 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 126' ' ' GLY . 34.1 t -54.19 156.16 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.239 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 84.98 -0.28 89.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.775 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.58 ' HB2' HD12 ' A' ' 108' ' ' ILE . 44.1 m-20 -85.85 127.65 34.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.837 0.351 . . . . 0.0 110.802 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.675 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -91.25 101.78 14.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.346 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.684 ' HA ' HG12 ' A' ' 160' ' ' VAL . 25.7 mt -70.07 106.69 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.723 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.98 -14.05 20.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.834 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 15.9 m -168.43 158.85 9.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.906 0.384 . . . . 0.0 111.355 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -147.16 121.18 2.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.948 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.8 m120 58.9 27.45 16.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.27 23.65 47.21 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.536 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -114.51 111.9 22.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -61.76 107.89 0.91 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.436 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.67 2.35 38.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.216 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -64.46 -16.95 63.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.329 . . . . 0.0 111.038 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -136.06 57.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.185 0.516 . . . . 0.0 109.81 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.17 96.9 1.74 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.509 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 140' ' ' ALA . 27.4 p -39.44 161.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.086 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.846 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.04 -26.79 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.81 -29.9 63.62 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.996 0.427 . . . . 0.0 111.029 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.895 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.6 mp0 -79.25 -27.03 42.37 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.146 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.641 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.46 -43.38 27.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.687 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.846 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.9 t -70.33 -29.77 40.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.048 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.405 ' O ' ' HB3' ' A' ' 151' ' ' LYS . 4.3 mt-30 -75.74 -32.46 60.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.82 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.22 -34.15 74.41 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.234 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.575 HD12 HD13 ' A' ' 96' ' ' ILE . 44.2 mt -83.67 -23.77 31.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.062 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.76 -16.11 35.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.972 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.1 OUTLIER -126.94 97.74 5.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.77 -174.83 5.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.829 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -102.06 -134.7 8.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.559 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.85 -5.15 35.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.645 0.259 . . . . 0.0 111.321 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -137.3 109.07 7.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.772 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.505 ' O ' HD12 ' A' ' 158' ' ' LEU . 21.9 t -107.85 110.92 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.539 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.0 t -85.07 86.62 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.452 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.66 HD21 HD21 ' A' ' 92' ' ' LEU . 5.0 mp -81.3 101.65 9.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.523 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -83.84 113.39 20.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.016 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.0 m -130.32 170.03 20.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.17 0.509 . . . . 0.0 111.976 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -141.94 120.43 12.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.079 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -69.74 108.15 3.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.904 0.383 . . . . 0.0 111.018 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.78 8.92 12.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.366 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 pttm 45.81 -168.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.776 0.322 . . . . 0.0 111.436 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.297 -0.858 . . . . 0.0 110.865 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.849 0.357 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -143.17 151.46 40.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.839 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.14 120.98 25.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.828 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.18 142.16 29.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.921 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 65.5 m -127.88 118.04 22.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.905 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.715 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p -127.57 138.67 54.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.01 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.99 138.33 53.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 157.52 34.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.91 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -103.99 -30.96 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.118 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.99 73.56 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.796 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 59.86 94.3 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 144.01 88.85 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.539 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.84 157.74 17.95 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.566 HD11 HD21 ' A' ' 158' ' ' LEU . 0.2 OUTLIER 60.84 -172.74 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.908 0.385 . . . . 0.0 110.84 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 158.02 64.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.353 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 1.056 HG22 HG23 ' A' ' 111' ' ' ILE . 28.9 pt -146.08 159.37 11.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -98.82 111.58 23.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.068 179.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.718 HD13 HD12 ' A' ' 149' ' ' LEU . 4.4 pt -105.34 170.38 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.04 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.8 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 13.6 ttpp -162.69 140.54 8.29 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.724 178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.432 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.97 170.96 43.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.338 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.83 90.71 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.42 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -26.73 60.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.772 0.32 . . . . 0.0 110.914 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.36 -52.09 62.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.577 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 103' ' ' LYS . 6.3 p30 -90.77 18.68 6.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.054 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 102' ' ' ASN . 0.0 OUTLIER 65.15 32.41 10.19 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.852 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.3 mtp -104.91 110.41 64.44 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.771 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 149.71 67.08 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.768 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -58.84 140.03 17.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.175 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.728 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.7 mt -146.29 170.31 17.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.302 0.572 . . . . 0.0 112.186 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.615 HD12 ' HB2' ' A' ' 127' ' ' ASP . 62.7 mt -92.81 145.54 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.558 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.48 ' HA ' HG13 ' A' ' 125' ' ' VAL . 8.6 t -140.37 -12.26 1.05 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.448 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -176.05 94.07 0.05 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.302 -0.559 . . . . 0.0 112.003 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.056 HG23 HG22 ' A' ' 94' ' ' ILE . 4.8 mt -69.59 141.53 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.808 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.686 ' HB3' HD12 ' A' ' 115' ' ' LEU . 32.1 m-85 -96.44 123.09 39.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.997 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -72.09 163.07 28.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.23 33.66 87.86 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.595 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.686 HD12 ' HB3' ' A' ' 112' ' ' PHE . 65.4 mt -144.36 -178.94 6.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.879 0.371 . . . . 0.0 110.864 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.715 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -55.7 -34.68 65.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.377 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -58.06 -56.93 15.7 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.914 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -10.47 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.096 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -79.27 -33.39 43.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.797 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.43 -19.19 18.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.297 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 47.11 45.31 15.94 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.218 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.04 54.99 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.4 OUTLIER -174.36 70.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.886 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.755 ' HA ' HD11 ' A' ' 111' ' ' ILE . 79.3 m-85 -84.94 156.17 21.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.183 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.48 HG13 ' HA ' ' A' ' 109' ' ' SER . 21.8 t -54.03 127.08 11.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.238 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 119.65 -14.17 10.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.613 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.615 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -70.43 122.51 19.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.81 0.338 . . . . 0.0 110.704 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.728 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -84.75 101.06 11.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.344 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.409 ' HA ' HG12 ' A' ' 160' ' ' VAL . 2.2 mp -74.18 113.08 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.698 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.03 -8.83 11.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.858 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -160.42 147.66 15.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.947 0.403 . . . . 0.0 111.21 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.23 129.13 6.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.848 ' ND2' HG13 ' A' ' 156' ' ' VAL . 2.2 m-80 57.65 26.69 13.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.904 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.02 29.97 44.42 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.321 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -120.34 121.45 38.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.764 0.316 . . . . 0.0 110.978 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -67.33 109.24 3.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.046 HD23 ' HB3' ' A' ' 140' ' ' ALA . 4.6 mt -89.49 9.86 24.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.098 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.6 m -59.09 -20.23 51.56 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.801 0.334 . . . . 0.0 110.93 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.2 m -137.76 58.45 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.284 0.564 . . . . 0.0 109.88 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.046 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -146.69 92.58 2.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.724 -179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 140' ' ' ALA . 62.6 p -38.58 161.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.107 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.825 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.36 -27.55 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.39 -27.81 62.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.793 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 1.6 mt-10 -82.27 -25.27 34.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.023 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.587 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.42 -42.14 23.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.654 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.9 t -72.12 -29.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.965 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -76.5 -32.53 58.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.797 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.36 -32.68 70.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.256 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.718 HD12 HD13 ' A' ' 96' ' ' ILE . 78.2 mt -85.21 -22.44 28.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.878 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -87.34 -18.84 29.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.148 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -119.33 79.99 1.5 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 148' ' ' ALA . 22.5 p -136.53 165.04 26.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.965 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -142.01 135.94 7.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.442 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 -135.89 0.62 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -69.89 141.12 53.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.818 0.342 . . . . 0.0 110.752 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.848 HG13 ' ND2' ' A' ' 133' ' ' ASN . 22.4 t -120.45 118.1 55.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.281 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.78 94.86 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.757 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD21 HD11 ' A' ' 92' ' ' LEU . 4.4 mt -87.52 94.74 9.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.097 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -78.89 116.46 19.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.215 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 129' ' ' ILE . 29.9 m -130.5 170.03 20.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.517 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -130.57 116.67 18.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.652 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.85 100.74 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.915 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.49 ' HE3' HD21 ' A' ' 107' ' ' LEU . 7.7 mtm -91.29 -16.68 27.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.342 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt 61.34 -81.31 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.895 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.814 0.34 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -148.62 153.11 37.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.58 117.8 33.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.958 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.465 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 21.8 t -92.26 88.6 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.018 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.561 ' OG1' HG22 ' A' ' 157' ' ' VAL . 86.5 m -84.5 112.47 20.42 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.093 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.525 ' CG2' ' HB1' ' A' ' 116' ' ' ALA . 10.9 p -118.02 142.38 32.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -90.96 159.38 16.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -95.54 145.9 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.042 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.25 -75.67 0.37 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -176.77 -56.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.43 -31.46 7.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.014 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.57 -92.22 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.88 -129.64 8.9 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 pp -93.89 126.83 39.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.66 70.05 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.366 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.644 HG23 ' HB2' ' A' ' 117' ' ' ALA . 1.1 pt -152.5 153.45 9.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 0.0 111.498 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 0.9 OUTLIER -113.44 115.61 28.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.893 179.216 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.5 pt -103.75 170.17 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.326 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.787 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -164.69 137.75 4.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.483 178.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.47 170.92 42.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.47 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -168.1 88.59 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.455 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -31.95 55.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.828 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -60.14 -37.68 80.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.272 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -90.75 10.44 25.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.732 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.4 mtpm? 66.13 30.77 9.21 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.824 0.345 . . . . 0.0 110.428 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.8 ttp -118.17 116.56 35.65 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.88 154.07 67.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.364 2.043 . . . . 0.0 111.896 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.656 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -59.71 139.95 18.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.933 0.396 . . . . 0.0 111.065 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.595 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.55 170.3 16.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.304 0.573 . . . . 0.0 112.402 -178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.705 HG21 HD11 ' A' ' 111' ' ' ILE . 2.7 mp -92.31 135.4 27.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.215 178.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 t -126.51 -10.89 6.26 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.408 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.3 OUTLIER -173.47 91.34 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.359 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 123' ' ' LEU . 5.4 mt -79.64 146.96 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.296 178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.78 153.05 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.19 140.09 38.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.821 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.48 -23.16 31.5 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.681 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.5 mt -88.08 -177.41 5.72 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.525 ' HB1' ' CG2' ' A' ' 84' ' ' VAL . . . -52.97 -38.8 62.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.329 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.808 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.49 -42.19 70.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -87.85 -11.53 47.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.28 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.8 mm-40 -71.5 -47.33 56.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.7 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -69.87 -16.05 63.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.208 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 46.21 41.45 8.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.371 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.43 59.52 1.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.226 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.818 ' O ' HD13 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -178.08 98.43 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.014 179.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.45 ' HA ' HD13 ' A' ' 111' ' ' ILE . 10.4 m-85 -116.5 149.52 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.6 p -46.32 128.97 2.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.485 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 123.94 -6.38 8.9 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.545 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -82.6 143.75 30.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 110.704 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.595 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -105.64 108.68 20.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.366 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.74 ' HA ' HG12 ' A' ' 160' ' ' VAL . 15.6 mt -72.03 100.76 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.755 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 130' ' ' LEU . 16.3 mt -97.84 -16.91 19.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.531 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 37.4 m -160.0 153.83 22.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.734 HG12 HD13 ' A' ' 137' ' ' LEU . 13.9 p -149.94 149.25 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 132' ' ' VAL . 1.3 p-10 43.13 31.62 0.37 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.242 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 69.86 49.23 36.68 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.539 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -147.4 144.17 28.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.104 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -82.96 108.52 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.81 HD21 ' HA ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -91.88 14.54 15.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.825 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.0 t -58.91 -17.41 24.0 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.314 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -133.41 56.95 1.83 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.229 0.538 . . . . 0.0 109.822 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.749 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -147.51 93.12 2.18 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.735 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 21.8 p -39.87 163.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.98 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.2 t-80 -47.45 -28.14 2.02 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -73.45 -28.55 62.02 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.03 0.443 . . . . 0.0 110.961 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.749 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 3.6 mt-10 -82.2 -23.43 35.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.243 178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.81 ' HA ' HD21 ' A' ' 137' ' ' LEU . . . -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.854 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.864 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.31 -32.08 36.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.336 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -78.16 -30.75 49.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.567 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.83 -32.92 71.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.011 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.613 HD12 HD13 ' A' ' 96' ' ' ILE . 62.9 mt -84.12 -25.63 29.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -90.18 -10.33 44.87 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 36.78 2.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.079 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 148' ' ' ALA . 65.1 p -130.27 159.24 37.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.759 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -164.63 135.68 3.86 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.98 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.0 mtpt 77.74 -7.33 1.84 Allowed 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -170.45 111.23 0.4 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.762 0.315 . . . . 0.0 111.098 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.59 HG12 HD23 ' A' ' 158' ' ' LEU . 22.8 t -123.24 89.83 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.079 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.561 HG22 ' OG1' ' A' ' 83' ' ' THR . 24.2 t -97.32 98.35 7.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.59 HD23 HG12 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -100.0 106.43 18.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -79.38 120.07 23.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.982 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.8 m -129.7 161.1 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.842 -179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.3 119.59 27.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.441 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.87 85.05 0.49 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 75.3 mtm -111.6 18.2 19.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.254 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 40.52 75.39 0.08 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.612 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.828 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.796 0.332 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -149.48 155.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.82 124.57 49.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.108 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 122' ' ' ALA . 17.3 t -105.86 148.26 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.546 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.8 m -114.63 106.01 13.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.818 0.342 . . . . 0.0 110.923 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.726 ' CG1' HD11 ' A' ' 158' ' ' LEU . 12.9 p -108.15 148.17 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -117.9 117.44 29.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.59 131.56 35.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.937 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.31 175.51 5.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.097 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -59.81 -32.14 70.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.998 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.01 91.43 6.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.131 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.78 152.21 0.19 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.603 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.72 -139.28 0.12 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.54 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.544 HD22 HD22 ' A' ' 149' ' ' LEU . 5.2 mp -68.86 -59.98 2.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.733 0.301 . . . . 0.0 110.849 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 108.82 50.4 0.74 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.521 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.644 HG21 HD13 ' A' ' 123' ' ' LEU . 1.6 pt -146.64 143.59 20.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.79 0.329 . . . . 0.0 111.324 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 109' ' ' SER . 1.3 t -106.02 104.22 13.88 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.704 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.7 pt -102.99 170.29 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.274 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.804 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.24 140.4 7.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.984 0.421 . . . . 0.0 110.629 178.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.435 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.96 170.87 43.13 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.336 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -157.5 86.51 0.12 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.429 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -34.62 65.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.747 0.308 . . . . 0.0 110.82 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.41 -36.31 77.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.074 0.464 . . . . 0.0 110.168 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.7 9.79 28.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.613 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mttm 64.56 32.2 11.74 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 8.1 ttp -110.11 121.44 41.7 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.108 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.91 144.6 53.75 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.299 1.999 . . . . 0.0 111.899 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -59.18 143.41 13.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.173 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.1 mp -144.39 170.38 16.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.258 0.551 . . . . 0.0 112.252 -178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 127' ' ' ASP . 8.5 mt -94.82 148.06 5.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.379 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.452 ' N ' ' O ' ' A' ' 95' ' ' SER . 75.2 p -139.97 -14.09 1.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 2.2 tttp -175.79 94.02 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.223 -0.591 . . . . 0.0 112.15 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.633 ' CG2' ' HB1' ' A' ' 117' ' ' ALA . 2.3 mt -69.64 159.86 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.677 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.725 ' HB3' HD12 ' A' ' 115' ' ' LEU . 16.0 m-85 -109.37 124.52 51.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -75.85 153.0 37.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 72.47 20.11 79.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.664 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.725 HD12 ' HB3' ' A' ' 112' ' ' PHE . 77.0 mt -130.94 -177.42 4.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.868 0.366 . . . . 0.0 110.603 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -54.63 -30.6 55.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.227 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.745 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -62.74 -51.38 67.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.169 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -79.24 -9.81 59.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.441 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -78.12 -47.93 17.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.981 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.7 p -78.59 -14.94 59.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 43.81 35.8 1.17 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.499 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.542 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -133.77 52.56 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.292 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.745 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.6 pp -176.58 91.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.945 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.573 ' HA ' HD11 ' A' ' 111' ' ' ILE . 16.9 m-85 -106.11 164.74 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.423 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.413 ' N ' HD11 ' A' ' 111' ' ' ILE . 11.2 p -61.68 143.71 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.072 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 105.63 -14.34 46.29 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.8 OUTLIER -76.36 122.29 24.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.772 0.32 . . . . 0.0 110.67 179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.98 108.92 16.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.233 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.448 ' HA ' HG12 ' A' ' 160' ' ' VAL . 34.0 mt -72.95 116.59 15.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.087 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.407 HD12 ' HB2' ' A' ' 161' ' ' LYS . 3.5 mt -114.92 -9.8 12.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.523 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.19 141.29 8.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.91 0.386 . . . . 0.0 111.077 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.75 HG12 HD13 ' A' ' 137' ' ' LEU . 12.6 p -145.14 136.48 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.013 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.5 t30 55.31 28.4 11.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.02 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.65 50.66 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.596 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.09 124.43 29.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.9 0.381 . . . . 0.0 110.896 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -60.49 107.92 0.74 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.018 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 132' ' ' VAL . 1.9 tp -85.42 4.25 36.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.182 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.3 m -68.47 -12.69 61.57 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.034 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.6 m -140.31 59.32 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.282 0.563 . . . . 0.0 109.803 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.929 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -157.4 97.81 1.65 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.567 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 ' O ' ' O ' ' A' ' 140' ' ' ALA . 58.4 p -38.66 161.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.255 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.828 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.8 t-80 -46.31 -28.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -72.47 -28.61 63.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.121 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.929 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.5 mp0 -79.01 -28.37 43.34 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.231 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.586 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.41 -43.33 27.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.676 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 142' ' ' HIS . 41.9 t -70.77 -25.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.088 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 8.5 mt-30 -77.73 -34.76 52.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.013 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.26 -29.3 63.77 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD22 HD22 ' A' ' 92' ' ' LEU . 70.8 mt -89.68 -21.96 22.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -89.07 -20.23 24.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.056 179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.45 ' O ' ' CG ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -119.02 94.44 4.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.28 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.548 HG21 ' CG2' ' A' ' 156' ' ' VAL . 11.6 p -146.82 166.84 25.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.87 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -92.33 -106.17 1.6 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.499 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.82 25.21 6.92 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -170.08 117.44 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.694 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.548 ' CG2' HG21 ' A' ' 152' ' ' THR . 20.5 t -127.2 109.95 21.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.479 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.23 90.92 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.726 HD11 ' CG1' ' A' ' 84' ' ' VAL . 0.7 OUTLIER -74.3 80.45 1.84 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.339 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.23 109.04 5.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 129' ' ' ILE . 6.3 m -135.94 154.48 34.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.742 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.407 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -109.36 170.01 8.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.346 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -108.06 98.3 7.88 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.859 0.362 . . . . 0.0 110.941 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -5.99 58.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.334 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.33 163.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.95 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.834 0.35 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.47 154.17 38.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -118.14 104.55 10.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.019 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.577 HG11 HD23 ' A' ' 123' ' ' LEU . 24.5 t -76.06 88.84 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.143 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.639 HG23 ' O ' ' A' ' 156' ' ' VAL . 38.6 m -77.45 128.75 34.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG11 ' HB1' ' A' ' 116' ' ' ALA . 19.9 t -108.81 142.94 20.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.74 133.54 35.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.051 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -164.21 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 66.42 32.73 7.34 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.853 0.359 . . . . 0.0 111.069 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.76 122.91 36.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.25 121.6 10.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.0 -23.0 35.19 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.632 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.95 -73.88 2.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.695 HD12 HD12 ' A' ' 94' ' ' ILE . 1.7 mm? -119.4 179.45 4.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.322 . . . . 0.0 110.815 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.666 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -168.22 80.4 0.1 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.491 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.958 HG22 HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -157.7 157.1 3.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.869 0.366 . . . . 0.0 111.313 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -107.75 99.51 8.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.975 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.71 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.3 pt -96.62 170.17 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.195 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.781 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.3 ptpt -163.84 139.1 6.19 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.07 0.462 . . . . 0.0 110.746 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -166.87 170.88 41.54 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.096 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.73 87.17 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.587 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.84 -35.23 70.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 110.702 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -57.7 -41.14 81.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.001 0.429 . . . . 0.0 110.362 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 1.3 p-10 -90.91 12.73 18.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.794 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 32.2 10.92 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.435 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 13.8 ttp -108.47 117.5 54.31 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.052 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.4 Cg_exo -69.55 147.86 65.15 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.424 2.082 . . . . 0.0 111.735 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -61.35 141.22 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.244 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.28 170.18 16.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.306 0.574 . . . . 0.0 112.378 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.771 HD12 ' HB2' ' A' ' 127' ' ' ASP . 26.6 mt -95.36 137.1 24.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.549 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 98.5 p -126.03 -15.87 5.72 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 2.8 tttp -173.84 90.89 0.08 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.915 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.958 HG23 HG22 ' A' ' 94' ' ' ILE . 5.7 mt -74.85 137.76 22.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.443 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.526 ' CB ' HD12 ' A' ' 115' ' ' LEU . 7.1 m-85 -82.68 157.78 23.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.405 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -106.88 138.62 42.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.98 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.2 -28.84 11.4 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.666 HD13 ' HA3' ' A' ' 93' ' ' GLY . 20.1 mt -79.17 -177.94 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.889 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.435 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -54.64 -36.15 64.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.754 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.76 -58.99 5.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.04 -9.97 59.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.27 -41.88 63.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.799 0.333 . . . . 0.0 110.747 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.83 -15.0 58.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.342 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 46.82 35.17 2.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.55 55.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.111 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 111' ' ' ILE . 1.5 pp -175.72 98.17 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.942 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.409 ' HA ' ' CD1' ' A' ' 111' ' ' ILE . 12.7 m-85 -112.69 155.72 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.125 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.7 t -47.44 149.5 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.93 -11.07 64.27 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.612 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.771 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -80.9 117.7 21.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.737 0.303 . . . . 0.0 110.932 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -82.01 115.66 21.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.147 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.716 ' HA ' HG12 ' A' ' 160' ' ' VAL . 37.7 mt -72.8 117.1 15.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.712 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.1 mt -96.67 -27.33 14.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.3 m -165.38 159.59 17.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.014 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG23 HD23 ' A' ' 158' ' ' LEU . 11.1 p -144.01 129.75 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.14 26.51 15.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.045 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.77 25.24 50.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.691 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -119.41 113.63 21.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 111.059 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -59.88 107.69 0.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.859 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.751 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.2 tp -83.0 0.69 43.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.288 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.2 p -58.07 -22.39 50.13 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.843 0.354 . . . . 0.0 110.806 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.22 56.58 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.263 0.554 . . . . 0.0 109.73 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.95 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.86 95.62 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.658 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.428 ' O ' ' O ' ' A' ' 140' ' ' ALA . 70.2 p -39.14 164.06 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.382 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.834 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.3 t-80 -48.2 -26.9 2.12 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.29 -23.29 60.27 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.153 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.95 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 1.3 mt-10 -84.52 -26.85 27.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.23 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.751 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -80.68 -39.77 26.62 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.768 178.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.7 t -73.37 -33.18 39.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.334 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.452 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 0.0 OUTLIER -78.4 -28.11 46.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.601 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -70.91 -33.28 70.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.755 178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.572 HD21 ' CD2' ' A' ' 158' ' ' LEU . 3.9 mt -83.89 -24.93 30.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.684 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.77 -14.78 38.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.134 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -111.46 33.51 4.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.853 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 71.5 p -77.4 175.59 9.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.037 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -177.06 133.66 2.31 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.335 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt 61.64 -129.66 0.73 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -69.7 131.93 45.34 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.777 0.322 . . . . 0.0 110.713 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 83' ' ' THR . 2.0 t -107.81 153.49 9.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 81' ' ' ARG . 43.2 t -148.25 123.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.97 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.572 ' CD2' HD21 ' A' ' 149' ' ' LEU . 1.3 mt -121.02 99.71 6.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.841 0.353 . . . . 0.0 111.052 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -80.09 114.75 19.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.662 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.716 HG12 ' HA ' ' A' ' 129' ' ' ILE . 28.3 m -131.88 168.5 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.429 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.46 118.9 10.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.55 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -69.95 100.12 1.53 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.984 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.6 23.42 5.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.069 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt 59.22 161.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.907 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.971 179.963 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.781 0.324 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.91 137.35 9.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.727 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.34 133.37 42.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.99 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 HD22 ' A' ' 123' ' ' LEU . 21.6 t -109.75 139.8 31.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.618 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 120' ' ' THR . 30.5 m -117.22 130.97 56.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.0 111.161 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.768 HG23 HD21 ' A' ' 158' ' ' LEU . 21.7 t -124.21 141.41 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.75 141.49 50.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.968 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -66.97 139.07 57.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.916 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 90' ' ' GLY . . . -110.26 179.1 4.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.145 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -48.5 81.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -121.47 81.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.063 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 87' ' ' ALA . . . 108.42 129.6 6.01 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.491 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -96.37 -53.21 1.48 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.525 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.763 HD11 ' O ' ' A' ' 149' ' ' LEU . 53.9 mt -110.22 158.08 18.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.863 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.714 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -149.74 72.87 0.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.387 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.744 HG21 HD12 ' A' ' 123' ' ' LEU . 5.5 pt -166.49 149.81 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.705 0.288 . . . . 0.0 111.036 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.513 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.31 118.56 36.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.224 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.706 HG13 ' NE2' ' A' ' 142' ' ' HIS . 5.1 pt -109.4 170.31 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.794 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.9 OUTLIER -161.47 138.18 8.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.398 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.31 170.82 43.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.383 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -162.69 90.18 0.11 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.454 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.537 ' HE ' HG23 ' A' ' 141' ' ' THR . 0.9 OUTLIER -57.97 -35.96 71.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.626 0.25 . . . . 0.0 110.805 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -55.52 -42.23 74.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.019 0.438 . . . . 0.0 110.285 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.401 ' ND2' ' HB2' ' A' ' 104' ' ' MET . 2.6 p-10 -90.92 14.5 13.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.876 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 63.79 31.04 14.42 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.713 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 17.1 ttt -108.37 114.19 59.54 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.793 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.7 Cg_exo -69.53 146.03 60.33 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.409 2.073 . . . . 0.0 111.937 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.534 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.1 mm -60.07 140.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.236 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -145.14 170.32 16.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.201 -178.845 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.941 HG21 HD11 ' A' ' 111' ' ' ILE . 46.8 mt -92.6 140.19 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.561 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.19 -9.07 2.98 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -178.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 3.6 ttmt -169.57 90.57 0.2 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.239 -0.585 . . . . 0.0 112.023 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.941 HD11 HG21 ' A' ' 108' ' ' ILE . 7.7 mm -70.98 161.23 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.578 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.667 ' HB3' HD12 ' A' ' 115' ' ' LEU . 2.4 m-85 -115.24 169.99 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.812 0.339 . . . . 0.0 110.923 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -122.65 155.31 36.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.897 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.32 29.35 74.8 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.638 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.667 HD12 ' HB3' ' A' ' 112' ' ' PHE . 48.4 mt -136.44 -178.36 5.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.853 0.358 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -58.23 -36.01 72.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.208 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -58.51 -53.94 52.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.45 -9.79 59.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.417 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -77.36 -41.14 41.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.783 0.325 . . . . 0.0 110.831 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -79.15 -13.32 59.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.36 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 42.61 38.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.53 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -138.07 43.22 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.158 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.744 HD12 HG21 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -172.86 94.93 0.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.946 179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.473 ' HA ' HG13 ' A' ' 111' ' ' ILE . 6.1 m-85 -120.38 164.84 15.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.947 0.403 . . . . 0.0 111.228 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.1 t -50.77 138.05 7.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.319 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 107.34 -13.12 40.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.576 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -77.4 131.39 38.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.793 0.33 . . . . 0.0 110.819 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -97.76 107.07 19.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.251 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.77 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.4 mt -73.31 118.2 18.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.608 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.1 pp -115.26 -10.81 12.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.855 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -159.37 154.57 25.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.877 0.37 . . . . 0.0 111.405 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 137' ' ' LEU . 21.8 t -152.56 137.21 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.054 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.9 t30 52.48 26.31 4.14 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.201 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.39 36.57 26.5 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.548 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -132.87 155.44 49.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.885 0.374 . . . . 0.0 110.929 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -89.16 107.34 18.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.943 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.5 tp -79.53 -4.38 51.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.212 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 67.3 m -59.67 -20.94 59.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.848 0.356 . . . . 0.0 110.906 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.4 m -128.34 53.87 1.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.231 0.539 . . . . 0.0 109.611 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.18 94.92 2.0 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.621 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.537 HG23 ' HE ' ' A' ' 100' ' ' ARG . 12.3 p -36.99 158.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 5.3 t-80 -47.41 -26.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.63 -27.77 58.55 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.892 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.641 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 3.2 mt-10 -80.73 -26.73 37.18 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.962 178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.534 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.56 -44.38 24.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.679 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 38.5 t -71.47 -27.02 27.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.232 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -79.38 -30.04 42.34 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.836 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 152' ' ' THR . . . -72.24 -32.94 67.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.302 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.763 ' O ' HD11 ' A' ' 92' ' ' LEU . 6.8 mt -85.11 -26.36 26.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.912 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.639 ' HD2' HG12 ' A' ' 146' ' ' VAL . 9.0 mttt -90.15 -12.32 38.57 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.509 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 40.7 mttt -127.69 90.75 3.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.694 HG21 HG13 ' A' ' 156' ' ' VAL . 1.3 p -148.59 -177.58 5.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -111.29 95.74 0.84 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.588 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? 59.8 -88.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.999 0.428 . . . . 0.0 111.132 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -78.34 144.33 36.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.941 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.694 HG13 HG21 ' A' ' 152' ' ' THR . 17.7 t -136.16 113.9 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.69 94.85 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.077 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.768 HD21 HG23 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -93.86 101.34 13.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.974 179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -74.49 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.312 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.9 m -140.29 160.34 25.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.484 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.56 117.93 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.665 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.8 110.55 5.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 13.3 mtt -135.03 21.74 3.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.191 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.55 117.4 11.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.834 0.349 . . . . 0.0 110.825 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.981 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.35 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.53 154.94 39.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -120.27 100.53 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.797 179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 123' ' ' LEU . 18.6 t -75.05 107.15 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.213 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.1 t -97.23 125.67 41.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.813 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.4 t -127.88 147.47 32.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.178 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -110.81 126.88 55.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.711 ' HE3' HG21 ' A' ' 156' ' ' VAL . 0.0 OUTLIER -74.39 171.5 13.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.963 -179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.74 -47.22 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -124.1 178.51 5.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.02 133.38 40.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.106 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.73 -46.84 0.67 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.553 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 104.02 -144.75 15.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.469 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 93' ' ' GLY . 0.1 OUTLIER -91.66 176.44 6.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.864 0.364 . . . . 0.0 110.917 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -127.08 79.31 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.514 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.654 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -159.37 150.47 6.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.871 0.367 . . . . 0.0 111.4 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.468 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -109.12 113.95 27.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.959 179.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.868 HG22 HD13 ' A' ' 108' ' ' ILE . 4.5 pt -105.01 170.23 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.435 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.788 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 1.5 mmtp -161.2 137.09 8.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.41 171.2 43.5 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.4 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.11 88.0 0.1 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.337 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.01 -35.44 64.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.795 0.331 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.71 -36.4 76.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.001 0.429 . . . . 0.0 110.408 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -90.59 8.22 35.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.774 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.07 30.54 4.39 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.9 0.381 . . . . 0.0 110.402 -179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.8 ttt -118.08 116.92 35.61 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.07 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.0 149.74 59.49 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.359 2.039 . . . . 0.0 112.183 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HA ' ' HA3' ' A' ' 98' ' ' GLY . 2.2 mm -59.56 140.44 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.984 0.421 . . . . 0.0 111.403 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.622 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.0 OUTLIER -143.88 170.32 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.055 -178.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.868 HD13 HG22 ' A' ' 96' ' ' ILE . 51.5 mm -92.58 138.04 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.616 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.2 p -130.7 -10.18 3.97 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 5.5 tttp -174.01 91.23 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.267 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.763 HG12 HD12 ' A' ' 123' ' ' LEU . 3.2 mt -76.68 149.42 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.45 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -94.41 145.31 24.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.888 0.375 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -95.59 136.73 35.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.85 -33.1 5.76 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.498 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.5 mt -76.44 -177.18 4.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.8 0.333 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.813 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -55.29 -33.25 63.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.307 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -56.32 -50.62 70.93 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.261 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.9 -9.83 57.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.33 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.16 -38.21 60.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.849 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.616 HG21 HG22 ' A' ' 84' ' ' VAL . 3.8 p -81.58 -16.71 50.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.292 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 46.58 37.8 4.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.372 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -140.83 52.12 1.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.234 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.763 HD12 HG12 ' A' ' 111' ' ' ILE . 1.0 OUTLIER -177.51 90.76 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.0 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.658 ' HA ' HD13 ' A' ' 111' ' ' ILE . 14.3 m-85 -106.45 151.11 25.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.231 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.414 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 11.6 p -46.88 128.13 2.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.366 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.04 -7.39 10.04 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.727 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -87.6 122.52 31.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 110.905 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -82.86 115.93 21.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' A' ' 108' ' ' ILE . 5.8 mt -77.99 98.48 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.963 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.568 HD13 ' HD3' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -91.11 -15.0 30.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.462 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.37 142.71 14.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.926 0.393 . . . . 0.0 111.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG22 HD22 ' A' ' 133' ' ' ASN . 11.8 p -145.34 143.45 22.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.958 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.687 HD21 HG13 ' A' ' 156' ' ' VAL . 2.6 m-80 55.99 26.19 9.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.023 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 74.6 35.48 51.35 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.441 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.11 144.97 37.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.911 0.386 . . . . 0.0 111.002 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.21 109.8 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 140' ' ' ALA . 3.9 tp -86.01 5.25 34.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.2 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.44 -23.0 35.69 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.853 0.358 . . . . 0.0 110.968 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 18.1 m -131.15 55.09 1.87 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.207 0.527 . . . . 0.0 109.792 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.01 ' HB1' ' HG2' ' A' ' 144' ' ' GLU . . . -143.46 89.35 2.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.887 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 140' ' ' ALA . 11.1 p -32.95 148.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.545 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.817 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.0 t-80 -48.27 -27.02 2.24 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.98 -38.05 64.26 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.163 0.506 . . . . 0.0 110.824 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 1.01 ' HG2' ' HB1' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -80.33 -22.99 40.9 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -76.42 -46.18 28.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.979 178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 142' ' ' HIS . 59.3 t -69.35 -30.58 46.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.87 178.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.33 -30.53 62.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.929 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.22 72.96 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.119 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.794 HD12 HD13 ' A' ' 96' ' ' ILE . 53.5 mt -79.36 -25.02 42.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.687 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HD3' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -90.07 -13.73 35.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.079 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.55 25.34 11.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.93 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 14.6 p -90.55 165.31 13.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.931 0.396 . . . . 0.0 111.053 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -156.01 138.88 6.22 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.297 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp 62.38 -130.72 0.59 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -69.76 122.26 18.85 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 120.837 0.351 . . . . 0.0 110.736 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.711 HG21 ' HE3' ' A' ' 86' ' ' LYS . 26.3 t -119.14 119.52 61.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.184 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 81' ' ' ARG . 21.6 t -95.48 114.88 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.143 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.45 HD23 HG23 ' A' ' 132' ' ' VAL . 0.9 OUTLIER -107.6 87.85 2.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.962 179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -75.13 114.44 13.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.517 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.572 HG12 ' HA ' ' A' ' 129' ' ' ILE . 35.7 m -129.47 169.94 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.481 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.568 ' HD3' HD13 ' A' ' 130' ' ' LEU . 6.1 mtpm? -140.15 116.53 10.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.835 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -69.98 92.39 0.72 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 14.5 mtp -95.07 -4.85 45.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.24 166.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.847 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.953 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.697 0.284 . . . . 0.0 111.379 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.489 ' HB2' HG23 ' A' ' 160' ' ' VAL . 3.0 mtt180 -123.92 156.84 35.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.946 0.403 . . . . 0.0 110.802 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.445 ' HD2' ' HG3' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -142.09 112.62 7.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.713 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.514 HG13 ' HB3' ' A' ' 122' ' ' ALA . 2.4 t -107.4 162.98 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.868 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 m -138.95 113.89 9.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.062 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 HD12 ' A' ' 158' ' ' LEU . 21.9 t -123.59 136.42 60.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.042 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.72 148.09 28.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.8 mtpt -135.19 31.59 3.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.79 169.65 3.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.096 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 64.04 -79.15 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -174.78 175.45 2.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.034 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.77 -164.06 12.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.437 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -157.64 160.87 30.98 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.428 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.446 HD22 HG11 ' A' ' 84' ' ' VAL . 87.4 mt -75.72 -176.78 3.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.407 ' HA3' HD13 ' A' ' 115' ' ' LEU . . . -149.54 77.47 0.23 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.589 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.651 HG23 ' HB2' ' A' ' 117' ' ' ALA . 0.2 OUTLIER -155.78 147.79 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 111.626 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.46 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -110.22 109.57 20.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.88 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.715 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.4 pt -108.28 170.33 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.447 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.774 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 12.6 tttt -163.6 139.83 6.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.968 0.413 . . . . 0.0 110.691 178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -169.87 170.86 43.08 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.586 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.41 88.49 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -28.76 44.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.761 0.315 . . . . 0.0 110.788 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -35.75 81.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.33 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.9 m-20 -90.61 7.73 37.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.664 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.5 mttt 69.67 30.34 3.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.577 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.1 mtp -123.14 117.47 28.27 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.59 158.45 57.13 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.302 2.002 . . . . 0.0 111.567 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.6 mm -60.09 142.4 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.809 0.338 . . . . 0.0 111.046 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.534 HD22 ' OXT' ' A' ' 165' ' ' GLU . 1.1 mp -143.83 170.2 16.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.313 0.578 . . . . 0.0 112.142 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.782 HD12 ' HB2' ' A' ' 127' ' ' ASP . 32.0 mt -93.5 145.45 7.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.698 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 60.2 m -136.33 -15.49 1.67 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.46 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 21.4 ttpt -176.21 92.49 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.45 -0.5 . . . . 0.0 112.185 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.782 HG12 HD12 ' A' ' 123' ' ' LEU . 3.5 mt -77.68 157.86 5.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.293 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.453 ' N ' HG22 ' A' ' 111' ' ' ILE . 10.8 m-85 -108.89 143.91 37.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.936 0.398 . . . . 0.0 111.166 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.64 139.82 30.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.068 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.09 -42.83 2.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.669 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 ' HA3' ' A' ' 93' ' ' GLY . 0.8 OUTLIER -65.43 -176.66 0.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.906 0.384 . . . . 0.0 111.088 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.74 -36.69 62.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.429 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -53.34 -59.43 4.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.3 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -11.96 60.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.323 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -37.86 67.87 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.74 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.03 -16.12 48.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.317 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 46.55 42.84 11.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.417 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.514 ' HB3' HG13 ' A' ' 82' ' ' VAL . . . -148.98 57.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.234 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.782 HD12 HG12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -179.67 93.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.629 ' HA ' HD13 ' A' ' 111' ' ' ILE . 16.0 m-85 -108.2 151.75 25.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.216 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 125' ' ' VAL . 11.5 p -55.76 125.31 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 128.32 -8.54 6.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.689 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.782 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -87.84 153.64 21.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.825 0.345 . . . . 0.0 110.995 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.55 106.1 15.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.622 ' CG1' HG12 ' A' ' 160' ' ' VAL . 4.5 mt -74.5 113.83 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -7.41 11.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.607 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -149.7 138.63 21.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.904 0.383 . . . . 0.0 111.18 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG12 HD12 ' A' ' 137' ' ' LEU . 11.1 p -133.3 126.74 53.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.887 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 53.8 t30 54.12 28.68 9.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 32.53 32.43 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.46 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -132.72 124.29 27.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.766 0.317 . . . . 0.0 111.062 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -63.56 111.25 2.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.06 HD23 ' HB3' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -85.42 5.53 30.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.094 179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 84.7 p -57.89 -21.72 44.75 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 110.955 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.49 51.88 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.306 0.574 . . . . 0.0 109.808 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 1.06 ' HB3' HD23 ' A' ' 137' ' ' LEU . . . -151.67 94.37 1.98 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.728 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 18.3 p -40.08 162.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.098 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.831 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.4 t-80 -48.26 -26.57 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.18 -28.14 61.15 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.956 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.785 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 4.3 mt-10 -79.42 -26.87 41.78 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.063 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 137' ' ' LEU . . . -78.05 -45.7 22.9 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.671 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 142' ' ' HIS . 22.4 t -70.62 -25.11 25.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.316 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.434 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 43.4 mt-30 -80.54 -30.92 37.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.14 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.55 -27.33 55.87 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.9 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.455 HD22 HD21 ' A' ' 158' ' ' LEU . 72.2 mt -87.86 -31.6 19.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.036 0.446 . . . . 0.0 111.213 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 2.0 ptmm? -90.39 -14.39 33.08 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.389 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -124.61 64.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.783 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.667 HG21 HG22 ' A' ' 156' ' ' VAL . 0.2 OUTLIER -125.6 156.65 38.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.14 -133.3 0.26 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.558 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.5 31.27 2.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -166.42 121.22 1.15 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.667 HG22 HG21 ' A' ' 152' ' ' THR . 15.5 t -134.29 95.71 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 t -78.42 106.47 9.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.863 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.479 HD12 HG23 ' A' ' 84' ' ' VAL . 1.9 mt -88.08 85.5 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.077 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.445 ' HG3' ' HD2' ' A' ' 81' ' ' ARG . 35.2 tt0 -79.77 116.2 19.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.889 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.622 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.7 m -126.66 167.55 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 111.855 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -132.25 114.31 14.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.566 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -69.9 93.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.759 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.24 -6.12 10.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.529 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt 55.03 27.22 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.711 0.291 . . . . 0.0 111.132 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.534 ' OXT' HD22 ' A' ' 107' ' ' LEU . 2.8 tp10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.961 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.784 0.326 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -150.89 146.3 26.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.788 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.403 ' HB3' HG13 ' A' ' 157' ' ' VAL . 2.6 mpt_? -102.32 138.22 39.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.014 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.729 HG11 HD23 ' A' ' 123' ' ' LEU . 21.6 t -114.98 92.7 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.005 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.612 ' O ' HG21 ' A' ' 120' ' ' THR . 0.3 OUTLIER -70.03 119.32 14.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.924 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 28.3 t -109.02 125.6 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.064 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -87.68 134.81 33.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -89.71 118.58 29.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -91.05 178.04 6.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.078 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.76 -53.52 45.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -124.09 93.35 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.054 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 175.97 -92.64 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.443 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.06 -174.57 34.27 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.408 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.33 119.91 8.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -112.33 75.46 0.22 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.524 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 96' ' ' ILE . 1.7 pp -156.64 159.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 111.626 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 3.2 t -118.58 119.14 33.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.006 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.701 HG23 HD12 ' A' ' 94' ' ' ILE . 3.6 pt -109.31 170.22 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.203 -179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.805 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.3 OUTLIER -162.67 138.96 7.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.1 0.476 . . . . 0.0 110.665 178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.29 170.87 43.27 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.173 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -155.62 83.42 0.15 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.458 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.57 -35.61 63.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.687 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 -37.51 78.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.026 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -90.81 10.72 25.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.653 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.2 mttp 63.82 32.51 13.41 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.863 0.363 . . . . 0.0 110.128 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtp -108.24 122.42 40.61 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.156 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.58 145.28 57.69 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.371 2.048 . . . . 0.0 111.666 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.559 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.2 mm -60.74 144.86 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.14 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 128' ' ' ALA . 3.9 mt -144.91 170.09 16.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.281 0.562 . . . . 0.0 112.13 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.736 ' CD1' HD11 ' A' ' 129' ' ' ILE . 45.5 mm -95.28 139.48 18.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.848 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 m -132.65 -6.59 3.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.418 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.6 tttt -172.69 89.73 0.09 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.299 -0.561 . . . . 0.0 112.291 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.702 ' CD1' HG21 ' A' ' 108' ' ' ILE . 49.2 mt -90.8 116.35 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.436 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 115' ' ' LEU . 70.4 m-85 -68.54 170.91 8.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.506 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.4 tttt -123.51 147.52 47.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.755 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 93.05 -24.97 22.28 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.73 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 112' ' ' PHE . 1.5 mt -85.47 -175.71 5.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.832 0.348 . . . . 0.0 110.902 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -54.91 -43.3 73.15 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.326 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' C ' HD11 ' A' ' 123' ' ' LEU . . . -50.29 -59.41 4.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.23 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.8 -11.44 60.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.281 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -71.29 -39.03 71.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.976 0.417 . . . . 0.0 110.485 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.612 HG21 ' O ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -73.89 -9.21 58.41 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.203 179.545 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 44.23 43.91 6.18 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.457 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -153.56 60.19 0.75 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.308 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -178.78 109.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.082 179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -132.87 149.34 52.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.104 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -46.5 128.16 2.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.487 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 120.99 4.8 10.09 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.754 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -100.9 128.48 46.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.799 0.333 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.738 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -87.69 113.61 23.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.736 HD11 ' CD1' ' A' ' 108' ' ' ILE . 9.3 mt -75.43 112.51 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.634 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 161' ' ' LYS . 4.9 mt -102.76 -15.28 16.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.29 151.37 9.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.925 0.393 . . . . 0.0 111.208 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 132' ' ' VAL . 10.6 p -140.78 126.38 19.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.835 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 57.02 27.32 13.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.998 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.3 27.91 38.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.551 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -124.36 115.94 21.79 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.875 0.369 . . . . 0.0 111.028 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.5 p30 -60.43 109.68 1.07 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.0 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.7 tp -84.13 2.68 38.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.143 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.7 p -63.66 -17.2 62.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.754 0.312 . . . . 0.0 111.105 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.7 m -135.22 56.98 1.82 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.102 0.477 . . . . 0.0 109.849 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.47 96.9 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.634 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 140' ' ' ALA . 22.6 p -39.02 162.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.324 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.833 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.5 t-80 -46.75 -27.94 1.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -71.66 -26.22 62.45 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.044 0.449 . . . . 0.0 111.221 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.943 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 6.5 mt-10 -83.28 -26.14 30.94 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.406 179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.98 -36.18 28.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.931 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' HIS . 44.7 t -76.92 -31.05 18.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.269 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.436 ' CG ' ' HA ' ' A' ' 144' ' ' GLU . 2.8 pp0? -80.82 -28.18 36.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.698 178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.31 -31.35 60.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.287 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 158' ' ' LEU . 42.2 mt -86.68 -25.97 24.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.981 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -90.05 -15.93 30.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.362 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 24.8 mttp -112.7 77.53 1.05 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.3 p -136.13 -178.09 4.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.952 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -107.01 -98.1 2.55 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.591 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.94 1.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.498 0.19 . . . . 0.0 111.449 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.15 104.63 4.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.769 0.319 . . . . 0.0 110.802 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.21 96.45 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.333 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 81' ' ' ARG . 22.8 t -77.77 92.14 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.845 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.95 HD21 HD21 ' A' ' 149' ' ' LEU . 2.5 mt -85.72 99.12 11.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.331 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -85.13 111.2 19.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.349 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 129' ' ' ILE . 33.4 m -129.99 164.77 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.016 0.436 . . . . 0.0 111.58 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -135.93 119.56 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.436 179.664 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.9 101.38 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 5.1 ptm -148.38 28.7 0.88 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.992 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.62 121.19 11.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.01 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.44 0 CA-C-O 120.839 0.352 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -170.01 157.83 6.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.881 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -107.99 142.48 38.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 122' ' ' ALA . 20.3 t -117.35 94.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.932 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -71.56 95.35 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG12 ' HD2' ' A' ' 86' ' ' LYS . 21.9 t -101.34 125.88 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 112.62 25.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' HG2' HD23 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -109.65 72.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.833 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -113.58 -35.34 5.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.019 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -84.19 -174.42 5.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.919 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.69 100.56 0.07 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -176.12 -165.75 32.39 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.492 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.04 40.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.524 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HD22 ' A' ' 115' ' ' LEU . 0.9 OUTLIER 59.78 -170.45 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.852 179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 175.46 76.54 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.405 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.718 HG21 ' CD1' ' A' ' 123' ' ' LEU . 3.5 pt -161.89 147.21 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.75 0.309 . . . . 0.0 111.138 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.459 ' HB3' ' CB ' ' A' ' 110' ' ' LYS . 1.2 t -107.74 121.38 44.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.358 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.725 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.4 pt -111.4 170.35 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.158 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.762 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 26.9 tttp -163.72 141.97 7.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.356 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 142' ' ' HIS . . . -168.98 170.93 42.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.44 -179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -170.05 91.04 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.573 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -57.35 -33.72 68.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.857 0.361 . . . . 0.0 110.623 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -58.57 -39.29 79.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.179 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -90.68 11.9 20.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.789 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.41 31.37 12.71 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 120.858 0.361 . . . . 0.0 110.37 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.6 ttt -115.31 113.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.117 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.44 153.29 70.61 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.523 2.149 . . . . 0.0 111.859 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.99 137.0 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 120.936 0.398 . . . . 0.0 111.25 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.539 HD23 ' CA ' ' A' ' 128' ' ' ALA . 1.1 mt -145.15 170.21 16.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.203 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.677 HG21 HD11 ' A' ' 111' ' ' ILE . 53.0 mt -98.75 141.31 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.13 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.605 ' HA ' HG23 ' A' ' 125' ' ' VAL . 2.7 t -140.16 -0.52 1.63 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 95' ' ' SER . 0.4 OUTLIER -164.75 87.28 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.349 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.677 HD11 HG21 ' A' ' 108' ' ' ILE . 13.2 mm -72.32 155.95 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.46 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' N ' HG22 ' A' ' 111' ' ' ILE . 15.5 m-85 -119.48 166.16 13.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.718 0.294 . . . . 0.0 110.935 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -121.9 148.14 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.991 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.55 21.83 49.59 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.688 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 92' ' ' LEU . 1.7 mp -140.31 175.57 9.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.792 0.329 . . . . 0.0 111.042 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -55.76 -29.8 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.405 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -57.59 -60.55 3.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.153 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.89 -9.94 59.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.415 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -73.82 -42.28 61.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 110.905 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 59.5 p -77.41 -14.59 59.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.324 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 48.5 28.45 1.73 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -127.58 47.58 2.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.871 0.367 . . . . 0.0 111.182 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.718 ' CD1' HG21 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -177.28 88.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 179.963 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.4 ' HA ' HG13 ' A' ' 111' ' ' ILE . 13.2 m-85 -113.15 163.7 14.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.243 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.1 p -61.86 133.49 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.127 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 118.93 -8.98 12.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.75 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.67 ' OD2' HD12 ' A' ' 108' ' ' ILE . 26.6 p30 -92.55 147.91 22.51 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.778 0.323 . . . . 0.0 110.77 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.539 ' CA ' HD23 ' A' ' 107' ' ' LEU . . . -105.69 115.19 29.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.715 ' HA ' HG12 ' A' ' 160' ' ' VAL . 7.3 mt -74.49 112.65 11.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.569 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.34 -21.92 13.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.842 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -159.75 152.07 20.95 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.102 0.477 . . . . 0.0 111.477 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 p -146.35 138.9 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.73 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.595 HD22 HG22 ' A' ' 152' ' ' THR . 3.7 t-20 53.09 25.33 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.129 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.56 36.93 25.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.595 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -135.75 129.08 32.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.787 0.327 . . . . 0.0 111.082 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.95 112.4 6.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.598 HD21 ' CB ' ' A' ' 145' ' ' ALA . 1.5 tp -81.85 0.65 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.062 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 35.4 t -58.6 -20.25 45.66 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.828 0.346 . . . . 0.0 111.125 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.3 m -131.41 55.31 1.87 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.203 0.525 . . . . 0.0 109.856 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.752 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.99 95.73 1.89 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.618 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 140' ' ' ALA . 1.3 p -39.1 161.86 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.291 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.849 ' O ' HG23 ' A' ' 146' ' ' VAL . 7.3 t-80 -48.29 -27.59 2.6 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 147' ' ' GLN . 3.2 t70 -75.14 -26.1 58.91 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.016 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.752 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 79.1 mm-40 -81.49 -26.2 35.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.921 178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.598 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.24 -45.21 23.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.476 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 142' ' ' HIS . 26.1 t -68.59 -30.89 48.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.919 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.488 ' HA ' ' HG2' ' A' ' 150' ' ' LYS . 17.0 mt-30 -72.9 -34.5 66.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.033 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.691 ' O ' HG23 ' A' ' 152' ' ' THR . . . -70.98 -31.01 67.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.627 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 158' ' ' LEU . 20.3 mt -76.05 -34.05 59.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.15 0.5 . . . . 0.0 110.806 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.488 ' HG2' ' HA ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -90.05 -10.67 43.96 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.561 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -104.56 41.29 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 148' ' ' ALA . 80.4 p -120.14 163.11 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.965 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -144.76 127.97 3.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.396 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.9 -125.71 0.4 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.88 133.55 47.48 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 152' ' ' THR . 16.2 t -132.34 127.87 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.831 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -90.98 105.12 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.432 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.921 HD21 HD21 ' A' ' 149' ' ' LEU . 2.6 mt -100.57 98.25 8.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -91.4 113.69 26.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.742 179.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.715 HG12 ' HA ' ' A' ' 129' ' ' ILE . 34.5 m -131.22 147.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.391 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -105.97 170.07 8.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.6 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -106.66 106.35 16.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.01 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.8 mtt -109.0 -3.84 17.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.357 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -71.39 137.6 48.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.893 0.378 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.41 ' N ' ' HG2' ' A' ' 161' ' ' LYS . 4.9 ttp85 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.743 0.306 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -150.14 153.84 37.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.19 130.43 56.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.893 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 122' ' ' ALA . 27.2 t -111.14 92.75 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.985 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -80.48 118.83 22.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.95 140.48 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.084 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.74 134.01 49.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -86.43 171.64 10.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.879 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 59.82 30.12 19.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.075 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.34 -43.43 2.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.809 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -163.05 30.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.015 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 132.36 -167.48 23.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.44 53.71 0.8 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.489 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.599 ' HA ' ' HB3' ' A' ' 116' ' ' ALA . 26.6 tp 60.36 110.97 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.347 . . . . 0.0 110.882 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.516 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -115.43 96.5 0.75 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.59 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 117' ' ' ALA . 16.7 pt -158.66 149.97 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.928 0.394 . . . . 0.0 111.429 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -109.11 121.08 44.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.891 179.181 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.954 HD13 HD12 ' A' ' 149' ' ' LEU . 4.5 pt -113.56 170.3 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.168 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.81 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 4.9 mttm -163.53 136.86 5.57 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.914 0.388 . . . . 0.0 110.639 178.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.404 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.28 170.68 43.13 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.176 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.67 93.87 0.11 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.472 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.39 -29.78 49.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.78 0.324 . . . . 0.0 110.828 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.19 -39.74 79.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.276 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.7 m-80 -90.78 11.79 21.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.616 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt 63.03 31.98 15.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.9 0.381 . . . . 0.0 110.285 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 2.0 ttp -113.54 118.86 42.76 Favored Pre-proline 0 N--CA 1.456 -0.173 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.064 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.53 148.79 67.36 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.364 2.043 . . . . 0.0 111.694 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.575 HG22 HD12 ' A' ' 129' ' ' ILE . 2.2 mm -58.0 141.55 14.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.192 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.04 170.3 16.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.31 0.576 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.888 HD12 ' HB2' ' A' ' 127' ' ' ASP . 34.5 mt -93.6 142.36 13.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.749 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.9 p -132.98 -9.62 3.03 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.456 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 25.8 tttt -175.47 91.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.444 -0.502 . . . . 0.0 112.085 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.768 HD11 HG21 ' A' ' 108' ' ' ILE . 2.5 mp -77.79 136.62 23.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.382 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -82.98 141.52 32.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.104 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 38.5 mttp -93.6 140.17 29.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.87 -20.28 46.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.792 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 115' ' ' LEU . 11.0 mt -90.42 -174.94 4.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.976 0.417 . . . . 0.0 111.134 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB3' ' HA ' ' A' ' 92' ' ' LEU . . . -50.95 -35.57 34.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.446 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 94' ' ' ILE . . . -56.58 -54.82 41.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -73.48 -13.84 61.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.358 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -70.97 -46.81 61.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.2 p -86.89 -16.67 35.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.297 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 45.7 33.65 1.53 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.431 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.673 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -120.78 42.72 2.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.493 ' O ' HD12 ' A' ' 123' ' ' LEU . 0.4 OUTLIER -169.43 94.73 0.3 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.005 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.74 ' HA ' HD13 ' A' ' 111' ' ' ILE . 11.2 m-85 -108.66 150.48 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 22.0 t -48.06 132.49 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.322 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 111.71 -4.56 27.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.705 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.888 ' HB2' HD12 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -83.23 137.02 34.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.787 0.327 . . . . 0.0 110.769 179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.58 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.47 107.84 20.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.587 ' CG1' HG12 ' A' ' 160' ' ' VAL . 8.4 mt -72.37 105.15 2.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.599 HD12 ' HB2' ' A' ' 161' ' ' LYS . 0.9 OUTLIER -94.58 -19.07 20.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.693 -179.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 14.7 m -158.55 147.23 18.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.095 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.62 HG12 HD13 ' A' ' 137' ' ' LEU . 11.3 p -139.82 132.5 35.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 56.25 27.59 11.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.96 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.92 31.56 43.22 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.88 130.22 35.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -68.35 108.6 3.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.709 HD21 ' CB ' ' A' ' 145' ' ' ALA . 2.8 tp -78.66 -3.35 43.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.229 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 54.6 m -56.67 -23.21 40.21 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.886 0.374 . . . . 0.0 110.945 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.0 m -124.91 51.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.832 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.81 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.26 94.53 1.94 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.633 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 47.2 p -37.58 157.98 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.124 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.832 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -46.89 -27.54 1.29 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -70.79 -29.1 65.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.004 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.81 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 0.9 OUTLIER -81.45 -27.1 34.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.13 178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.709 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -79.53 -39.9 30.84 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.802 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 142' ' ' HIS . 47.2 t -73.24 -30.11 30.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.108 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.4 -30.66 53.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.849 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.07 -32.96 67.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.388 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.954 HD12 HD13 ' A' ' 96' ' ' ILE . 42.6 mt -83.42 -26.42 30.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.02 -13.65 35.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.418 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.3 mttm -133.6 96.25 3.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.015 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.6 HG21 HG22 ' A' ' 156' ' ' VAL . 24.9 p -125.12 -169.56 2.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.788 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -137.68 76.93 0.35 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.547 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.12 25.29 10.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.101 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -170.13 137.14 1.51 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 152' ' ' THR . 7.7 t -134.67 77.29 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.218 -179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.6 t -74.45 92.15 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.493 HD21 HD22 ' A' ' 149' ' ' LEU . 1.1 mp -88.49 97.34 11.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.296 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.97 108.83 15.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.082 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.587 HG12 ' CG1' ' A' ' 129' ' ' ILE . 35.1 m -128.88 145.87 35.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.102 0.477 . . . . 0.0 111.916 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.599 ' HB2' HD12 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -121.49 130.81 53.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.367 179.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.79 99.7 1.4 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.85 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mmt -110.86 -3.93 15.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.468 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.45 -43.62 6.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.896 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.906 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.845 0.355 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 156.31 6.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.855 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.44 125.59 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.829 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 123' ' ' LEU . 17.3 t -96.5 85.88 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.13 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -77.56 104.9 8.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.599 HG11 ' HB1' ' A' ' 116' ' ' ALA . 21.5 t -101.91 135.04 40.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.203 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.93 143.4 42.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 1.2 mptt -71.59 81.33 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.24 95.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.057 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 64.15 -79.33 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -136.8 115.35 11.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.077 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.9 107.95 0.25 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.437 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.48 -76.03 1.25 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.504 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 6.2 tp -140.95 160.77 39.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.786 0.327 . . . . 0.0 110.871 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -160.83 72.4 0.22 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.526 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.656 HG22 HG23 ' A' ' 111' ' ' ILE . 1.5 pt -160.23 150.97 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.831 0.348 . . . . 0.0 111.175 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.453 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.52 109.84 21.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.215 179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.687 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.9 pt -101.07 170.1 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.061 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.802 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.1 OUTLIER -163.23 138.87 6.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.687 178.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.13 170.9 43.22 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.142 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -159.46 87.13 0.11 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.585 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -37.51 69.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.805 0.336 . . . . 0.0 110.693 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -58.29 -36.91 74.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.256 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.73 9.05 31.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.769 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt 66.68 31.42 7.65 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.89 0.376 . . . . 0.0 110.324 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 3.3 ttm -112.92 119.85 41.91 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.202 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.71 148.66 59.4 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.359 2.039 . . . . 0.0 111.969 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.625 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.7 mm -60.35 142.58 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 0.0 111.289 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.609 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.4 mt -144.82 170.36 16.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.225 0.536 . . . . 0.0 112.158 -178.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.662 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -91.28 142.36 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.508 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.404 ' HA ' HG23 ' A' ' 125' ' ' VAL . 63.2 m -133.3 -14.36 2.61 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.453 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 7.0 tttp -175.4 91.36 0.05 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.083 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.685 HG23 ' HB1' ' A' ' 117' ' ' ALA . 2.6 mp -73.22 142.06 15.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.34 178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.702 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.4 m-85 -87.59 158.27 18.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.214 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 ttpp -104.44 163.27 12.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.946 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.14 23.42 52.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 112' ' ' PHE . 82.2 mt -130.9 -176.19 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.758 0.313 . . . . 0.0 110.81 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.599 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -52.6 -39.52 61.69 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.685 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -57.65 -52.22 66.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -76.01 -9.75 58.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.335 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -76.34 -46.15 28.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.813 0.34 . . . . 0.0 110.851 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -17.8 48.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.381 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 46.72 36.23 3.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.264 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -134.19 52.55 2.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.235 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -172.63 92.53 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.987 0.422 . . . . 0.0 111.016 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.621 ' HA ' HD13 ' A' ' 111' ' ' ILE . 13.7 m-85 -105.46 154.72 19.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.404 HG23 ' HA ' ' A' ' 109' ' ' SER . 11.3 p -53.66 132.5 16.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.173 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 122.23 -15.14 8.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.711 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.568 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.9 m-20 -74.7 150.66 39.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 0.0 110.762 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.609 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -109.28 106.44 16.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.308 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.752 ' HA ' HG12 ' A' ' 160' ' ' VAL . 18.2 mt -71.18 96.63 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.718 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -97.75 -12.29 22.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.767 -179.589 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.28 143.73 21.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 0.0 111.16 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' HB1' ' A' ' 148' ' ' ALA . 10.3 p -133.24 137.5 53.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.94 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 20.9 p30 44.18 30.99 0.5 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.33 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.91 43.98 13.1 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.542 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -140.69 127.69 20.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.993 0.425 . . . . 0.0 110.993 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -60.07 108.53 0.79 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.963 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.477 HD13 HG12 ' A' ' 132' ' ' VAL . 5.7 tp -89.87 10.83 22.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.095 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 p -65.46 -13.48 58.87 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.24 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.2 m -135.59 57.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.244 0.545 . . . . 0.0 109.958 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.882 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -152.29 94.13 1.89 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.831 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 35.4 p -42.34 166.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.809 ' O ' HG23 ' A' ' 146' ' ' VAL . 2.7 t-80 -49.16 -26.7 2.98 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.92 -29.21 60.9 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.945 0.402 . . . . 0.0 110.757 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.882 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 20.6 mt-10 -82.47 -23.93 34.47 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.939 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.625 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -80.76 -42.37 21.9 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.859 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.8 t -73.84 -28.33 24.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.047 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -79.15 -30.6 43.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.676 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.893 ' O ' HG23 ' A' ' 152' ' ' THR . . . -71.98 -33.18 67.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.142 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 96' ' ' ILE . 60.5 mt -84.58 -25.11 28.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.79 179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' CD ' HG12 ' A' ' 146' ' ' VAL . 27.0 mtpt -90.12 -13.22 36.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.352 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.4 pttt -104.02 -5.63 21.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.893 HG23 ' O ' ' A' ' 148' ' ' ALA . 5.1 p -68.34 156.83 36.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -141.88 140.73 10.34 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.282 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.2 -128.92 0.66 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -69.83 124.63 24.5 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.888 0.375 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.507 HG13 HG21 ' A' ' 152' ' ' THR . 21.1 t -114.89 119.24 61.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.137 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.5 t -95.43 91.75 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.45 94.24 8.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.995 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -80.92 119.31 23.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 129' ' ' ILE . 30.8 m -132.11 170.09 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.429 ' HE3' HD11 ' A' ' 130' ' ' LEU . 48.1 mttt -141.26 119.85 12.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.77 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -70.01 101.47 1.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.21 -8.17 14.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.394 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 tttt 63.2 133.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.879 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.779 0.323 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.2 ptp85 -159.15 145.89 16.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.769 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -103.28 126.98 50.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 84' ' ' VAL . 12.6 t -99.27 88.77 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.104 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.0 m -79.75 93.13 5.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.821 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.725 HG22 HG21 ' A' ' 120' ' ' THR . 25.5 t -100.47 128.49 52.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.173 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -86.45 130.11 34.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.72 163.34 17.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.13 -42.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -167.17 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.84 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 62.2 178.87 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.08 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -69.78 -60.07 5.19 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.527 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -137.63 -104.11 0.66 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.519 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.1 tp -115.88 -64.55 1.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.556 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 125.06 58.61 0.17 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.481 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.724 HD12 HG23 ' A' ' 96' ' ' ILE . 1.1 pp -159.98 148.56 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.729 0.299 . . . . 0.0 111.112 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.465 ' CB ' ' HB3' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -107.19 110.81 22.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.267 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.748 HD13 HD12 ' A' ' 149' ' ' LEU . 3.4 pt -103.99 170.12 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.887 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.809 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -165.04 138.16 4.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.96 0.409 . . . . 0.0 110.833 178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.409 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.08 170.61 43.0 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.074 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.54 87.84 0.12 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.533 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.75 -33.76 61.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.338 . . . . 0.0 110.59 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.67 -36.11 77.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -90.67 8.42 34.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 mttp 66.82 31.65 7.21 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.163 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -110.86 121.69 40.18 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.105 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.55 145.24 57.73 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.406 2.071 . . . . 0.0 111.687 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 142' ' ' HIS . 2.8 mm -59.18 140.71 17.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.281 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 128' ' ' ALA . 1.2 mt -144.0 170.43 15.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 112.407 -178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.828 HD12 ' O ' ' A' ' 127' ' ' ASP . 3.1 mt -94.21 145.81 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.376 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 39.2 m -135.95 -11.24 2.01 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.465 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 1.2 ttmp? -174.46 91.5 0.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.181 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.767 HG12 HD12 ' A' ' 123' ' ' LEU . 2.4 mp -75.23 150.0 6.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -100.86 134.28 44.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.116 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -79.46 151.26 30.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.733 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.32 -52.14 4.46 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.514 HD13 ' CA ' ' A' ' 93' ' ' GLY . 18.4 mt -57.89 -177.91 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.908 0.385 . . . . 0.0 111.13 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.439 ' HB1' ' CG1' ' A' ' 84' ' ' VAL . . . -56.69 -33.4 66.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.279 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 111' ' ' ILE . . . -52.23 -53.28 45.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.128 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -85.33 -9.96 56.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.155 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.69 -31.91 63.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.755 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.725 HG21 HG22 ' A' ' 84' ' ' VAL . 2.6 p -92.35 -12.32 32.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.323 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 44.0 38.6 2.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.538 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.67 54.08 1.41 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.165 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.767 HD12 HG12 ' A' ' 111' ' ' ILE . 1.3 pp -177.9 88.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.963 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.727 ' HA ' HD13 ' A' ' 111' ' ' ILE . 35.1 m-85 -105.03 158.97 16.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.074 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 26.3 t -52.61 138.95 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.205 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.53 -10.85 33.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.694 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.828 ' O ' HD12 ' A' ' 108' ' ' ILE . 0.5 OUTLIER -82.33 113.92 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 110.813 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.606 ' HB2' ' CD2' ' A' ' 107' ' ' LEU . . . -76.25 112.41 12.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.366 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.897 ' HA ' HG12 ' A' ' 160' ' ' VAL . 21.2 mt -75.38 98.93 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.785 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.2 mt -103.38 -11.05 18.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.699 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.402 ' CB ' ' HB3' ' A' ' 159' ' ' GLU . 2.5 m -153.51 143.58 22.15 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.023 0.439 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 p -143.92 130.3 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.872 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.81 27.23 4.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.062 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.1 37.07 22.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.521 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -130.9 123.15 28.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.906 0.384 . . . . 0.0 111.012 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -62.82 106.89 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.072 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.459 HD21 ' CB ' ' A' ' 145' ' ' ALA . 4.1 tp -91.67 13.1 19.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.961 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.7 m -67.78 -13.24 61.96 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.66 59.47 1.63 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.309 0.576 . . . . 0.0 109.837 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.944 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -152.84 95.11 1.95 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.671 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.429 ' O ' ' O ' ' A' ' 140' ' ' ALA . 82.8 p -38.51 163.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.702 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.811 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.0 t-80 -47.03 -27.7 1.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.79 -24.9 61.82 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.212 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.944 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.0 mm-40 -82.48 -30.01 30.2 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.278 0.561 . . . . 0.0 110.186 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -78.66 -39.35 37.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.749 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.9 t -73.36 -30.3 30.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.197 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -77.2 -29.88 54.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.011 178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.94 -33.57 66.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.263 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.748 HD12 HD13 ' A' ' 96' ' ' ILE . 58.1 mt -81.6 -26.83 34.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.8 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -13.81 34.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.244 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -123.99 80.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.993 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.08 164.86 36.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.789 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -143.4 148.3 19.99 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.582 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.2 tttm 59.73 -138.33 0.7 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 143.03 52.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.5 t -126.45 107.82 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 81' ' ' ARG . 23.0 t -78.55 92.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.106 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 mp -88.25 86.89 7.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.402 ' HB3' ' CB ' ' A' ' 131' ' ' SER . 7.0 tt0 -77.18 124.49 27.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.393 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.7 m -135.93 169.26 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.744 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.55 130.54 38.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.581 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.83 95.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.864 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 8.5 mtt -124.84 23.57 7.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.183 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.39 111.21 12.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.939 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.881 179.987 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.87 0.367 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.29 149.79 27.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.473 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -107.32 124.34 49.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.055 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.726 ' O ' HD12 ' A' ' 158' ' ' LEU . 22.8 t -101.95 92.54 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.3 m -76.35 118.11 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 HG21 ' A' ' 120' ' ' THR . 27.8 t -123.8 125.13 70.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.145 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.08 138.6 50.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.953 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 15.9 mttt -71.69 -179.57 2.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 -69.43 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.149 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.8 -66.34 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.2 -52.69 4.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.998 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.58 153.85 46.25 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.509 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.73 82.36 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.526 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 mp 59.9 109.68 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.733 0.301 . . . . 0.0 110.959 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -141.46 82.27 0.23 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.492 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.696 HG22 ' HA ' ' A' ' 111' ' ' ILE . 1.3 pt -159.88 151.91 5.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.741 0.305 . . . . 0.0 111.007 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.484 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.1 t -105.92 122.89 47.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.339 179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.695 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.7 pt -109.37 170.37 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.178 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.798 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -161.76 139.42 8.86 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.418 178.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.07 170.76 43.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.404 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.53 84.44 0.1 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.696 HH11 HG23 ' A' ' 141' ' ' THR . 0.2 OUTLIER -55.63 -27.02 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.805 0.336 . . . . 0.0 110.849 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -57.71 -49.67 75.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.786 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 104' ' ' MET . 6.7 p30 -90.8 14.29 13.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.086 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 72.69 31.2 1.69 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.702 0.287 . . . . 0.0 111.098 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.41 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 3.1 ttp -106.62 111.42 63.97 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.937 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 13.0 Cg_exo -69.54 147.83 65.13 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.41 2.073 . . . . 0.0 111.934 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.604 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.8 mm -60.21 137.75 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.986 0.422 . . . . 0.0 111.259 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.07 170.39 16.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.142 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.959 HG21 HD11 ' A' ' 111' ' ' ILE . 60.6 mt -94.52 141.63 14.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.624 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 m -138.89 -3.35 1.63 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 14.8 tttm -161.59 86.32 0.65 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.309 -0.557 . . . . 0.0 112.042 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.959 HD11 HG21 ' A' ' 108' ' ' ILE . 5.7 mm -76.91 122.73 32.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.741 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -92.26 147.9 22.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.784 0.326 . . . . 0.0 111.005 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.57 152.96 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.015 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.5 -26.47 19.69 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.642 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -95.9 177.42 5.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.912 0.387 . . . . 0.0 110.94 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.37 -27.3 15.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.209 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.551 ' CB ' HG23 ' A' ' 94' ' ' ILE . . . -53.79 -66.69 0.35 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.208 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -75.82 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.131 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -73.08 -34.12 66.04 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.822 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.503 HG21 HG22 ' A' ' 84' ' ' VAL . 36.8 p -82.02 -16.51 50.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.372 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 46.56 29.9 1.01 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.219 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.7 32.94 3.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.663 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.4 pp -163.24 105.17 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.445 ' HA ' HG13 ' A' ' 111' ' ' ILE . 4.5 m-85 -127.85 171.43 11.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.182 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 38.3 t -57.19 148.01 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.023 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 97.91 -1.36 59.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.68 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.527 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.8 m-20 -84.38 137.74 33.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.737 0.303 . . . . 0.0 110.735 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.86 101.77 12.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.347 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.638 HG13 HG12 ' A' ' 160' ' ' VAL . 2.3 mp -74.33 112.19 11.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.712 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 5.5 mt -110.93 -14.86 13.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.827 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 2.3 m -157.5 149.65 22.53 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.892 0.377 . . . . 0.0 111.169 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.632 HG12 HD22 ' A' ' 133' ' ' ASN . 21.5 t -144.25 128.21 13.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.001 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.632 HD22 HG12 ' A' ' 132' ' ' VAL . 13.7 p30 44.55 29.92 0.45 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.571 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.73 38.65 8.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.753 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 112.34 11.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.806 0.336 . . . . 0.0 110.927 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -61.21 103.51 0.3 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.934 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.702 HD11 ' HA ' ' A' ' 145' ' ' ALA . 2.5 tp -76.68 -12.32 59.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.154 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 p -57.39 -22.01 39.96 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.921 0.391 . . . . 0.0 110.939 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.0 m -127.18 53.31 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.231 0.539 . . . . 0.0 109.794 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.741 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -156.16 96.76 1.73 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.625 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.696 HG23 HH11 ' A' ' 100' ' ' ARG . 0.6 OUTLIER -38.81 160.54 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.113 179.829 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.8 t-80 -47.53 -27.51 1.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.36 -28.15 60.99 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.972 0.415 . . . . 0.0 110.916 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.741 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 2.9 mm-40 -82.05 -25.19 34.83 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.869 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.702 ' HA ' HD11 ' A' ' 137' ' ' LEU . . . -79.19 -44.25 22.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.575 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 39.5 t -71.04 -29.79 38.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.975 178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -76.82 -30.53 56.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.762 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.08 -33.28 70.07 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.174 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.558 HD21 HD23 ' A' ' 158' ' ' LEU . 10.8 mt -85.75 -22.42 27.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.064 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.446 ' HD2' HG12 ' A' ' 146' ' ' VAL . 0.0 OUTLIER -86.92 -19.47 28.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.203 179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.02 31.44 5.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.646 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.902 HG22 HG22 ' A' ' 156' ' ' VAL . 52.3 m -136.87 94.6 2.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.799 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -93.78 174.6 34.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.44 -129.36 0.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.88 131.13 43.98 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 120.88 0.371 . . . . 0.0 110.693 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.902 HG22 HG22 ' A' ' 152' ' ' THR . 17.9 t -133.86 109.51 13.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.223 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG13 ' HB2' ' A' ' 81' ' ' ARG . 29.9 t -86.31 95.56 4.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.726 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -89.02 99.77 12.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 -179.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.99 107.78 14.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.377 179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.638 HG12 HG13 ' A' ' 129' ' ' ILE . 22.2 m -125.95 164.62 25.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.562 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -126.36 99.69 5.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.389 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -69.71 109.48 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.36 2.0 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.251 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.79 131.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.935 0.398 . . . . 0.0 110.959 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.925 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.752 0.31 . . . . 0.0 111.152 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.83 26.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.58 142.79 33.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HG ' ' A' ' 158' ' ' LEU . 19.6 t -118.42 90.07 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.876 HG23 HG22 ' A' ' 157' ' ' VAL . 3.6 m -81.48 109.6 16.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.7 t -108.53 143.7 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -116.89 143.17 46.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.98 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -143.14 166.91 23.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -111.74 -174.63 2.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.94 -30.81 66.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.975 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.15 130.65 56.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.017 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.53 -155.38 33.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.474 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.3 157.22 33.2 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.6 tp 62.13 150.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 176.22 69.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.545 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.768 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.4 pp -161.24 152.98 4.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 111.428 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m -111.1 116.32 30.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 109.956 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.697 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -108.46 170.25 2.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.201 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.799 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -162.59 138.77 7.44 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.544 178.46 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.446 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.17 170.93 43.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.139 -179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -156.99 89.95 0.11 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.613 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.08 -37.98 72.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 0.0 110.621 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -56.32 -38.13 70.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.275 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -90.88 11.48 22.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.4 32.77 16.68 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 120.848 0.356 . . . . 0.0 110.112 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' A' ' 105' ' ' PRO . 12.0 ttt -107.92 120.1 48.09 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.17 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 104' ' ' MET . 12.8 Cg_exo -69.57 142.36 48.56 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.372 2.048 . . . . 0.0 111.674 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.632 HG22 HD12 ' A' ' 129' ' ' ILE . 2.1 mm -58.27 143.1 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.204 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.585 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.1 mt -144.45 170.26 16.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.246 0.546 . . . . 0.0 112.324 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.862 HD12 ' HB2' ' A' ' 127' ' ' ASP . 86.5 mt -91.19 143.63 10.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.585 178.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 m -135.07 -10.26 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.0 OUTLIER -174.71 91.55 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.424 -0.51 . . . . 0.0 112.088 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.739 HG12 HD12 ' A' ' 123' ' ' LEU . 3.3 mt -76.22 154.85 5.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.504 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.744 ' HB3' HD12 ' A' ' 115' ' ' LEU . 29.1 m-85 -108.56 133.01 53.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.964 0.411 . . . . 0.0 111.182 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -85.89 145.84 26.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.993 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.3 -5.36 83.46 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.775 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.744 HD12 ' HB3' ' A' ' 112' ' ' PHE . 9.1 mt -107.01 -175.95 2.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' A' ' 119' ' ' GLN . . . -51.97 -37.73 54.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.792 ' HB1' HD11 ' A' ' 123' ' ' LEU . . . -54.44 -56.78 15.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.273 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.404 ' HB2' ' HA ' ' A' ' 113' ' ' LYS . 0.9 OUTLIER -76.45 -9.98 59.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.34 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.416 ' HB2' ' HA ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -73.99 -40.64 62.82 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.87 0.367 . . . . 0.0 110.719 179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.79 -16.73 46.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.256 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 46.63 46.43 14.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.354 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -152.79 58.14 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.263 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.792 HD11 ' HB1' ' A' ' 117' ' ' ALA . 1.3 pp -178.41 77.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.03 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.549 ' HA ' HD13 ' A' ' 111' ' ' ILE . 67.2 m-85 -92.34 152.85 19.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.299 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.433 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 12.8 p -48.55 134.82 5.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.08 33.47 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.424 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.862 ' HB2' HD12 ' A' ' 108' ' ' ILE . 2.1 m-20 -72.18 115.42 11.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.809 0.338 . . . . 0.0 110.687 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.585 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -77.86 108.19 10.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.491 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.807 ' HA ' HG12 ' A' ' 160' ' ' VAL . 22.1 mt -69.94 126.54 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.586 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.509 HD12 ' HG3' ' A' ' 161' ' ' LYS . 89.1 mt -112.3 -17.09 12.82 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.4 ' CB ' ' HG3' ' A' ' 159' ' ' GLU . 0.4 OUTLIER -159.58 163.79 34.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.027 0.441 . . . . 0.0 111.512 -179.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 137' ' ' LEU . 21.7 t -151.59 127.56 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.92 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.592 HD22 HG22 ' A' ' 152' ' ' THR . 3.8 t-20 58.19 28.78 17.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 78.56 27.63 56.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.74 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -123.44 131.1 53.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.783 0.325 . . . . 0.0 111.134 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -63.92 108.68 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.995 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 132' ' ' VAL . 4.0 tp -82.93 1.05 41.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.273 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.56 -18.56 59.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.804 0.335 . . . . 0.0 111.013 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 55.79 1.88 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.209 0.528 . . . . 0.0 109.84 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.777 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -151.49 93.87 1.94 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.796 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -40.89 163.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.036 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.808 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.24 -27.96 1.73 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -74.77 -29.22 61.06 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.987 0.422 . . . . 0.0 110.949 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.777 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.4 mt-10 -81.49 -25.39 36.05 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.898 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.567 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.31 -43.73 23.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.671 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.808 HG23 ' O ' ' A' ' 142' ' ' HIS . 46.8 t -71.08 -28.99 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.98 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -77.25 -31.12 54.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.596 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.411 ' O ' HG23 ' A' ' 152' ' ' THR . . . -69.78 -33.76 72.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.176 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.0 mt -86.17 -23.01 26.7 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.731 ' HD3' HG12 ' A' ' 146' ' ' VAL . 3.3 mptt -90.09 -14.28 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.554 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.411 ' HG2' ' HA ' ' A' ' 148' ' ' ALA . 6.6 ptpt -90.16 -6.06 55.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.565 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.592 HG22 HD22 ' A' ' 133' ' ' ASN . 77.8 p -81.62 177.43 8.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.758 0.313 . . . . 0.0 110.924 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -173.4 -40.11 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.638 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.39 -15.46 13.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 111.476 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -155.56 138.48 15.37 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.055 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.819 HG12 HD23 ' A' ' 158' ' ' LEU . 19.1 t -139.43 77.6 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.15 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.876 HG22 HG23 ' A' ' 83' ' ' THR . 30.7 t -86.64 91.19 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.83 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.819 HD23 HG12 ' A' ' 156' ' ' VAL . 0.3 OUTLIER -100.72 115.61 30.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.4 ' HG3' ' CB ' ' A' ' 131' ' ' SER . 1.7 mm-40 -85.25 129.01 34.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.206 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.807 HG12 ' HA ' ' A' ' 129' ' ' ILE . 17.2 m -135.46 162.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.137 0.494 . . . . 0.0 111.671 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HG3' HD12 ' A' ' 130' ' ' LEU . 6.4 mtpt -135.72 130.52 34.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.317 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.86 116.95 10.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.036 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.2 mtp -117.47 -4.2 11.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.319 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.9 mttt 61.57 156.18 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.898 0.38 . . . . 0.0 110.904 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.865 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 120.856 0.36 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 -158.23 164.85 36.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.793 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 159' ' ' GLU . 0.0 OUTLIER -121.67 118.97 30.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 83' ' ' THR . 21.4 t -94.16 156.06 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.724 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 120' ' ' THR . 22.7 m -120.93 142.9 49.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 116' ' ' ALA . 21.8 t -130.87 130.57 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.005 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.99 162.3 13.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.56 88.91 3.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.25 171.57 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -65.9 -31.73 72.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.76 33.12 2.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.008 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.01 179.0 51.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.497 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 116' ' ' ALA . . . -116.22 -169.38 15.41 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.551 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 149' ' ' LEU . 7.9 mt 59.38 -179.0 0.08 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.795 0.331 . . . . 0.0 110.915 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.487 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 132.78 66.94 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.513 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.9 HG22 HG23 ' A' ' 111' ' ' ILE . 3.3 pt -158.16 154.63 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.863 0.363 . . . . 0.0 111.505 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.447 ' O ' ' N ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -107.45 102.84 12.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.097 179.295 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.696 HG13 ' NE2' ' A' ' 142' ' ' HIS . 3.8 pt -97.95 170.13 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.234 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.796 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.81 138.81 6.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.874 0.369 . . . . 0.0 110.763 178.321 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -169.68 170.88 43.02 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.6 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.29 88.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.455 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -31.91 61.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.873 0.368 . . . . 0.0 110.733 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -61.14 -37.26 82.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 29.0 m-20 -90.56 8.58 33.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.809 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.8 mttp 69.17 30.59 4.29 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.866 0.365 . . . . 0.0 110.494 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.3 ttt -119.17 115.77 34.28 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.88 153.19 68.67 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.289 1.992 . . . . 0.0 111.853 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.693 HG13 HD23 ' A' ' 137' ' ' LEU . 2.7 mm -58.37 139.26 18.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.937 0.398 . . . . 0.0 111.116 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.691 HD23 ' HA ' ' A' ' 128' ' ' ALA . 2.3 mt -144.57 170.36 16.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.425 -178.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.816 HG21 HD11 ' A' ' 111' ' ' ILE . 28.0 mm -89.4 143.49 11.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.693 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 95' ' ' SER . 19.8 t -130.52 -18.49 3.16 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 95' ' ' SER . 0.0 OUTLIER -177.32 92.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.975 0.417 . . . . 0.0 111.97 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.9 HG23 HG22 ' A' ' 94' ' ' ILE . 3.3 mt -77.49 121.18 29.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.394 178.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB3' HD12 ' A' ' 115' ' ' LEU . 8.0 m-85 -73.34 161.25 30.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.362 -179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.5 tttt -106.46 166.99 10.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.794 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 66.18 24.83 72.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.622 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD12 ' HB3' ' A' ' 112' ' ' PHE . 5.1 mt -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.735 0.302 . . . . 0.0 110.836 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.665 ' HB2' ' HA2' ' A' ' 91' ' ' GLY . . . -56.81 -39.11 73.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.266 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.692 ' HA ' HD21 ' A' ' 123' ' ' LEU . . . -55.85 -54.38 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.269 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.28 -9.89 59.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.402 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.44 -31.3 37.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.784 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 83' ' ' THR . 6.8 p -92.12 -15.79 27.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.319 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.02 37.7 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.269 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -135.68 53.49 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.192 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.837 HD13 HG21 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -171.7 108.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.018 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.432 ' HA ' HD13 ' A' ' 111' ' ' ILE . 5.4 m-85 -123.82 151.39 43.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.3 t -51.76 126.62 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.271 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 121.3 -5.93 10.9 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.696 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -79.68 138.4 37.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.765 0.316 . . . . 0.0 110.764 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.857 ' HB3' ' HG3' ' A' ' 161' ' ' LYS . . . -98.22 102.54 14.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.244 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.81 ' HA ' HG12 ' A' ' 160' ' ' VAL . 4.2 mt -72.42 99.25 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.767 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.07 -8.01 20.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.687 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.06 153.92 16.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.947 0.404 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -151.0 124.24 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.941 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.5 30.88 20.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.832 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 77.5 24.85 64.44 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.493 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -114.06 123.7 50.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 111.041 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.67 105.92 2.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.693 HD23 HG13 ' A' ' 106' ' ' ILE . 0.3 OUTLIER -90.41 11.94 20.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.226 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.2 m -61.88 -17.29 56.03 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.806 0.336 . . . . 0.0 111.083 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.0 m -137.21 58.72 1.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.217 0.532 . . . . 0.0 109.754 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.895 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.29 94.42 2.22 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.574 -179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.7 OUTLIER -39.41 163.5 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.135 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.839 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.3 t-80 -47.97 -27.32 2.14 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -74.05 -23.71 59.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.13 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.895 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 4.7 mt-10 -84.49 -25.51 28.81 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.248 179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.643 ' CB ' HD21 ' A' ' 137' ' ' LEU . . . -81.35 -39.11 25.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.751 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 142' ' ' HIS . 40.6 t -73.99 -33.77 37.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.279 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.428 ' HG2' ' HA ' ' A' ' 144' ' ' GLU . 0.6 OUTLIER -78.86 -27.42 44.11 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.816 178.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 144' ' ' GLU . . . -73.89 -30.48 62.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.112 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.461 HD12 HD13 ' A' ' 96' ' ' ILE . 39.2 mt -86.8 -25.03 24.81 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.99 -15.8 31.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.464 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.9 mttp -108.21 33.69 4.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.954 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 11.3 t -137.76 132.2 32.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.829 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -130.53 179.47 16.89 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.637 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.7 mttp 60.11 -138.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -70.59 114.32 8.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.791 0.329 . . . . 0.0 110.903 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 25.2 t -112.61 149.55 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.8 t -124.99 107.39 18.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.984 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.46 HD12 HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -93.0 94.38 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.947 -179.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 20.3 tt0 -82.75 112.53 19.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.744 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.81 HG12 ' HA ' ' A' ' 129' ' ' ILE . 19.1 m -137.18 170.14 18.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.415 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.857 ' HG3' ' HB3' ' A' ' 128' ' ' ALA . 14.5 pttm -131.4 107.07 8.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.539 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -69.95 110.03 4.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.947 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 1.6 mmt -145.14 28.13 1.24 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -140.58 158.93 43.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.887 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.807 0.337 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.22 142.19 7.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.795 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -109.43 128.93 55.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.039 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' O ' HD12 ' A' ' 158' ' ' LEU . 19.5 t -104.67 87.59 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.982 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.0 m -80.19 109.64 14.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.021 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.4 t -103.8 141.45 19.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.965 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.65 114.21 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -91.42 72.29 6.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.913 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.41 -70.68 0.3 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -143.17 -56.18 0.41 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.822 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -98.81 115.25 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.036 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.62 ' CA ' ' HB2' ' A' ' 116' ' ' ALA . . . 103.35 112.47 3.69 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.52 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.672 ' C ' HD23 ' A' ' 92' ' ' LEU . . . -140.11 86.63 0.2 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.575 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.672 HD23 ' C ' ' A' ' 91' ' ' GLY . 0.9 OUTLIER 45.64 -168.28 0.01 OUTLIER 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.755 0.312 . . . . 0.0 111.425 -179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 94' ' ' ILE . . . 143.05 77.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.623 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.812 HG22 ' HA ' ' A' ' 111' ' ' ILE . 2.5 pp -162.23 154.67 3.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.757 0.313 . . . . 0.0 111.01 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.7 t -105.58 131.89 52.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.259 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.703 HG13 ' NE2' ' A' ' 142' ' ' HIS . 4.8 pt -121.59 170.37 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.801 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.2 OUTLIER -163.75 137.18 5.49 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.979 0.418 . . . . 0.0 110.937 178.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 106' ' ' ILE . . . -170.18 170.72 43.12 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.235 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -169.47 94.85 0.11 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.521 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -54.22 -30.1 48.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 110.821 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -60.3 -35.95 76.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.364 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -90.61 8.59 33.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.559 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 66.16 31.15 8.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.409 -179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 17.0 mtp -120.21 120.79 29.83 Favored Pre-proline 0 N--CA 1.454 -0.239 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.84 154.46 67.4 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.267 1.978 . . . . 0.0 111.682 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.591 HD12 ' CB ' ' A' ' 145' ' ' ALA . 2.5 mm -59.3 140.32 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 120.931 0.396 . . . . 0.0 111.107 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' A' ' 128' ' ' ALA . 1.9 mt -143.59 170.19 16.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.31 0.576 . . . . 0.0 112.158 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 111' ' ' ILE . 40.4 mm -82.94 152.6 3.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.979 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 53.1 m -145.11 -6.08 0.67 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 0.2 OUTLIER -172.22 91.08 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.423 -0.511 . . . . 0.0 112.086 179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.812 ' HA ' HG22 ' A' ' 94' ' ' ILE . 15.5 mm -77.9 103.24 4.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.711 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -75.26 133.4 41.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.935 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.31 153.83 17.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.977 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.8 -26.26 21.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.671 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mt -93.3 174.13 7.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.054 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.62 ' HB2' ' CA ' ' A' ' 90' ' ' GLY . . . -53.92 -30.24 45.51 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -53.04 -63.71 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.105 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -76.23 -10.11 59.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.231 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -71.92 -35.75 69.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.699 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.03 -9.62 59.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.452 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 42.98 32.88 0.45 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.564 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -132.16 42.76 3.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.085 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 111' ' ' ILE . 1.8 pp -174.56 94.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.958 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.476 ' HA ' HG13 ' A' ' 111' ' ' ILE . 10.5 m-85 -115.3 168.21 10.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.302 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 126' ' ' GLY . 40.6 t -59.12 157.58 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' N ' HG12 ' A' ' 125' ' ' VAL . . . 89.13 -11.44 69.44 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.749 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.33 140.72 40.05 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.856 0.36 . . . . 0.0 110.723 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.651 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -104.16 109.14 20.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.299 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.538 ' HA ' HG12 ' A' ' 160' ' ' VAL . 49.0 mt -71.89 115.41 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.525 179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 161' ' ' LYS . 41.2 mt -105.53 -17.22 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.833 -179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -164.82 157.78 16.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.33 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.665 HG11 ' HB1' ' A' ' 148' ' ' ALA . 9.9 p -144.13 122.87 6.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.999 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 59.21 31.4 21.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.9 22.05 62.16 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.622 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -111.74 140.78 46.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.784 0.326 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.02 107.04 16.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.939 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.484 HD13 HG12 ' A' ' 132' ' ' VAL . 1.1 mp -84.06 2.12 40.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.36 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.9 m -61.5 -18.9 61.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.811 0.339 . . . . 0.0 110.876 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -136.3 57.7 1.77 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.183 0.516 . . . . 0.0 109.734 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.91 ' HB1' ' CB ' ' A' ' 144' ' ' GLU . . . -153.3 95.91 1.99 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.641 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.413 ' O ' ' O ' ' A' ' 140' ' ' ALA . 0.6 OUTLIER -38.68 161.94 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.2 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.827 ' O ' HG23 ' A' ' 146' ' ' VAL . 3.7 t-80 -47.39 -26.47 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 38.6 p30 -71.77 -27.38 62.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.966 0.412 . . . . 0.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.91 ' CB ' ' HB1' ' A' ' 140' ' ' ALA . 0.2 OUTLIER -81.19 -27.58 35.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.961 178.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.591 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -78.65 -41.99 29.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.771 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 142' ' ' HIS . 37.7 t -72.34 -28.55 29.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.026 178.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -76.6 -31.59 57.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.696 178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.665 ' HB1' HG11 ' A' ' 132' ' ' VAL . . . -69.89 -36.7 75.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.987 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 96' ' ' ILE . 35.7 mt -80.34 -24.48 39.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.746 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 146' ' ' VAL . 12.3 mttp -87.73 -15.0 38.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.105 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.31 -102.68 0.19 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 148' ' ' ALA . 17.5 p 54.89 177.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.888 0.375 . . . . 0.0 111.132 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -134.55 -104.7 0.82 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.15 -2.9 54.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.533 0.206 . . . . 0.0 111.527 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -149.59 144.63 26.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.767 0.317 . . . . 0.0 110.927 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.4 t -127.72 81.78 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.133 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.425 HG13 ' HB2' ' A' ' 81' ' ' ARG . 33.1 t -79.43 93.17 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.071 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.448 ' CD2' HD22 ' A' ' 149' ' ' LEU . 0.4 OUTLIER -87.95 99.12 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.079 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.78 115.24 20.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.544 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 129' ' ' ILE . 24.8 m -129.64 167.91 23.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.955 0.407 . . . . 0.0 111.535 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HG3' HD12 ' A' ' 130' ' ' LEU . 4.6 mtpt -140.36 116.78 10.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.527 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.93 100.86 1.65 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.911 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.5 mtt -112.55 -5.89 13.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.37 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 56.46 170.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.81 0.338 . . . . 0.0 111.079 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.727 0.298 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.51 163.75 27.28 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.86 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.644 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -115.27 110.93 20.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG11 HD23 ' A' ' 123' ' ' LEU . 5.8 t -82.27 92.51 2.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.1 m -78.45 97.5 5.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.9 t -94.51 140.1 17.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.169 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.58 120.62 42.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.27 79.31 4.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.21 37.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.056 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.17 23.95 5.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.076 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 53.82 29.42 9.7 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.344 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -144.9 -79.68 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.571 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.63 ' O ' ' HB3' ' A' ' 116' ' ' ALA . . . 127.84 -120.7 3.54 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.434 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -106.11 147.29 29.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.341 . . . . 0.0 110.993 -179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.698 ' O ' HG23 ' A' ' 94' ' ' ILE . . . -138.99 84.35 0.23 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.441 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.782 HG21 ' CD1' ' A' ' 123' ' ' LEU . 2.2 pt -165.38 155.77 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.718 0.294 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.478 ' HB2' ' HB3' ' A' ' 110' ' ' LYS . 1.2 t -107.44 121.72 45.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.201 179.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.703 HD11 HG22 ' A' ' 146' ' ' VAL . 3.7 pt -111.93 170.25 3.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.178 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.789 ' HA ' ' NE2' ' A' ' 142' ' ' HIS . 0.0 OUTLIER -163.44 137.35 5.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.589 178.328 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.421 ' N ' ' CD2' ' A' ' 142' ' ' HIS . . . -170.05 170.91 43.2 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.59 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.5 83.19 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.392 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -54.4 -26.28 29.48 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 110.976 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -59.48 -47.73 84.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.571 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.54 13.87 14.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.075 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 72.24 30.93 1.98 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.803 0.335 . . . . 0.0 110.887 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.0 mmm -110.34 111.16 57.83 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.824 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.85 149.67 66.63 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.435 2.09 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 129' ' ' ILE . 2.7 mm -60.59 137.79 22.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.958 0.409 . . . . 0.0 111.277 -179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.694 HD23 ' HA ' ' A' ' 128' ' ' ALA . 5.0 mt -146.94 149.54 33.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.347 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.817 HD13 ' HB2' ' A' ' 127' ' ' ASP . 4.2 mp -80.3 138.52 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.48 177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.792 ' HA ' HG23 ' A' ' 125' ' ' VAL . 1.3 p -134.72 -1.82 2.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -178.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 95' ' ' SER . 1.8 ttmt -161.71 86.93 0.66 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.21 -0.596 . . . . 0.0 112.042 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.754 ' HA ' HG22 ' A' ' 94' ' ' ILE . 10.0 mm -71.74 132.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.675 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 115' ' ' LEU . 36.0 m-85 -95.06 161.86 13.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.808 0.337 . . . . 0.0 110.959 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -115.68 155.57 27.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.81 27.53 66.78 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.608 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 112' ' ' PHE . 4.9 mt -139.67 173.65 11.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.344 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 91' ' ' GLY . . . -55.64 -31.85 62.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.081 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.505 ' HB1' HG23 ' A' ' 94' ' ' ILE . . . -57.63 -59.48 5.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.859 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.55 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.34 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -37.04 56.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.1 p -79.26 -16.66 56.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.32 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 43.63 40.67 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.479 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.3 33.91 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.271 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.782 ' CD1' HG21 ' A' ' 94' ' ' ILE . 2.2 pp -165.56 102.97 0.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.008 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . 0.448 ' HA ' HG13 ' A' ' 111' ' ' ILE . 9.1 m-85 -118.35 165.49 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.343 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.792 HG23 ' HA ' ' A' ' 109' ' ' SER . 9.8 p -54.02 139.08 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.223 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.59 -6.05 54.91 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.762 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.817 ' HB2' HD13 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -76.13 135.86 39.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.803 0.335 . . . . 0.0 110.755 179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.694 ' HA ' HD23 ' A' ' 107' ' ' LEU . . . -98.9 103.51 15.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.376 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 106' ' ' ILE . 5.5 mt -69.99 91.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.639 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 87.5 mt -91.14 -10.98 39.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.666 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.59 143.36 16.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.959 0.409 . . . . 0.0 111.092 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.411 HG12 ' ND2' ' A' ' 133' ' ' ASN . 22.0 t -145.91 132.06 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.411 ' ND2' HG12 ' A' ' 132' ' ' VAL . 65.4 m-80 56.01 24.1 7.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.173 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.39 33.58 31.34 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.545 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.13 145.94 40.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.879 0.371 . . . . 0.0 111.043 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -81.55 112.71 19.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.998 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 1.2 tp -81.14 -0.28 39.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.088 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.05 -22.66 16.69 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.791 0.329 . . . . 0.0 111.141 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.9 m -122.62 50.68 1.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.188 0.518 . . . . 0.0 109.853 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.508 ' HB1' ' HB3' ' A' ' 144' ' ' GLU . . . -149.38 93.02 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.771 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.1 p -38.89 160.04 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.186 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.82 ' O ' HG23 ' A' ' 146' ' ' VAL . 4.5 t-80 -47.93 -28.32 2.63 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.26 -30.96 60.62 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.65 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.508 ' HB3' ' HB1' ' A' ' 140' ' ' ALA . 6.6 mm-40 -80.97 -24.17 38.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.767 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.568 ' CB ' HD12 ' A' ' 106' ' ' ILE . . . -79.1 -44.29 22.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.869 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 142' ' ' HIS . 42.1 t -70.66 -29.96 40.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.147 178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -77.25 -30.77 54.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.904 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.88 -31.7 66.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.342 179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 158' ' ' LEU . 68.7 mt -85.27 -24.81 27.59 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.92 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.08 -14.32 34.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.211 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -120.91 68.46 0.87 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 31.7 p -122.08 176.25 5.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.086 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -152.84 136.88 5.56 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.415 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 61.16 -136.19 0.59 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -69.92 122.67 19.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.78 0.324 . . . . 0.0 111.054 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 21.7 t -103.72 105.35 18.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.979 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 81' ' ' ARG . 24.3 t -80.64 88.61 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.241 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.764 HD21 HD22 ' A' ' 149' ' ' LEU . 0.7 OUTLIER -87.03 82.2 7.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.77 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -71.9 110.55 6.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.805 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 129' ' ' ILE . 32.3 m -128.19 150.82 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.246 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.99 108.95 16.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -70.64 108.28 4.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.856 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.84 27.98 6.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.014 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? 68.33 -68.77 0.16 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.008 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.313 -0.851 . . . . 0.0 110.917 -179.974 . . . . . . . . 1 1 . 1 stop_ save_